<!DOCTYPE html>
<html lang="en"><head>
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge"><!-- Begin Jekyll SEO tag v2.8.0 -->
<title>Voiding Dysfunction | Pediatric Urology Book</title>
<meta name="generator" content="Jekyll v4.2.2" />
<meta property="og:title" content="Voiding Dysfunction" />
<meta name="author" content="Arlen AM, Gundeti MS, López P-J, Rove KO" />
<meta property="og:locale" content="en" />
<meta name="description" content="By Israel Franco, MD,1 Sarah Lambert, MD,1 &amp; Anka J. Nieuwhof-Leppink, PhD2 1 Yale School of Medicine, New Haven, CT, USA 2 Department of Medical Psychology and Social Work and Urology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, the Netherlands" />
<meta property="og:description" content="By Israel Franco, MD,1 Sarah Lambert, MD,1 &amp; Anka J. Nieuwhof-Leppink, PhD2 1 Yale School of Medicine, New Haven, CT, USA 2 Department of Medical Psychology and Social Work and Urology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, the Netherlands" />
<link rel="canonical" href="https://beta.pediatricurologybook.com/es/book/chapters/03-20_voiding-dysfunction/" />
<meta property="og:url" content="https://beta.pediatricurologybook.com/book/chapters/03-20_voiding-dysfunction/" />
<meta property="og:site_name" content="Pediatric Urology Book" />
<meta property="og:type" content="article" />
<meta property="article:published_time" content="2023-01-29T15:14:26-07:00" />
<meta name="twitter:card" content="summary" />
<meta property="twitter:title" content="Voiding Dysfunction" />
<script type="application/ld+json">
{"@context":"https://schema.org","@type":"BlogPosting","author":{"@type":"Person","name":"Arlen AM, Gundeti MS, López P-J, Rove KO"},"dateModified":"2023-01-29T15:12:55-07:00","datePublished":"2023-01-29T15:14:26-07:00","description":"By Israel Franco, MD,1 Sarah Lambert, MD,1 &amp; Anka J. Nieuwhof-Leppink, PhD2 1 Yale School of Medicine, New Haven, CT, USA 2 Department of Medical Psychology and Social Work and Urology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, the Netherlands","headline":"Voiding Dysfunction","mainEntityOfPage":{"@type":"WebPage","@id":"https://beta.pediatricurologybook.com/book/chapters/03-20_voiding-dysfunction/"},"url":"https://beta.pediatricurologybook.com/book/chapters/03-20_voiding-dysfunction/"}</script>
<!-- End Jekyll SEO tag -->
<meta http-equiv="Content-Language" content="es">
<link rel="alternate" hreflang="en" href="https://beta.pediatricurologybook.com/book/chapters/03-20_voiding-dysfunction/"/>
<link rel="alternate" hreflang="es" href="https://beta.pediatricurologybook.com/es/book/chapters/03-20_voiding-dysfunction/"/>
<link rel="alternate" hreflang="zh" href="https://beta.pediatricurologybook.com/zh/book/chapters/03-20_voiding-dysfunction/"/>
<link rel="alternate" hreflang="pt" href="https://beta.pediatricurologybook.com/pt/book/chapters/03-20_voiding-dysfunction/"/>

  <!-- Favicon -->
  <link rel="icon" href="https://beta.pediatricurologybook.com/es/favicon.ico" type="image/x-icon" > <!-- 32×32 -->
  <link rel="icon" href="https://beta.pediatricurologybook.com/assets/site-img/favicons/icon.svg" type="image/svg+xml">    <!-- res independent -->
  <link rel="apple-touch-icon" href="https://beta.pediatricurologybook.com/assets/site-img/favicons/apple-touch-icon.png"> <!-- 180×180 -->
  <link rel="manifest" href="/es/manifest.webmanifest">
  
  <!-- Mobile Metas -->
  <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1.0, shrink-to-fit=no">

  <!-- Analytics --><!-- Vendor CSS -->
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/vendor/bootstrap/css/bootstrap.min.css">
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/vendor/fontawesome-free/css/all.min.css">
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/vendor/animate/animate.min.css">
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/vendor/rs-plugin/css/navigation.css">
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/vendor/owl.carousel/assets/owl.carousel.min.css">
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/vendor/owl.carousel/assets/owl.theme.default.min.css">
  
  <!-- Theme CSS -->
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/css/theme.css">
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/css/theme-elements.css">

  <!-- Skin CSS -->
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/css/skins/skin-pub.css"> 
  
  <!-- Theme Custom CSS -->
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/css/custom.css">
  
  <!-- JS Libraries -->
  <script src="https://beta.pediatricurologybook.com/assets/vendor/modernizr/modernizr.min.js"></script>
</head>
<body data-plugin-page-transition>

    <div class="body" aria-label="Content">    
    
    <header id="header" data-plugin-options="{'stickyEnabled': true, 'stickyEnableOnBoxed': true, 'stickyEnableOnMobile': true, 'stickyStartAt': 108, 'stickySetTop': '-109px', 'stickyChangeLogo': true}">
      <div class="header-body">
        <div class="header-container container">
          <div class="header-row">
            <div class="header-column">
              <div class="header-row">
                <div class="header-logo">
                  <a class="site-title" rel="author" href="https://beta.pediatricurologybook.com/es/">
                    <img width="254" height="165" data-sticky-width="126" data-sticky-height="80" data-sticky-top="95" alt="Pedatric Urology Book" src="https://beta.pediatricurologybook.com/assets/site-img/pediatricurologybook-new.svg">
                  </a>
                </div>
              </div>
            </div>
            <div class="header-column justify-content-end">
              <div class="header-row pt-3 mb-3">
                <nav class="header-nav-top">
                  <ul class="nav nav-pills">
                    <li class="nav-item nav-item-anim-icon d-none d-md-block">
                      <a class="nav-link pl-0" href="https://beta.pediatricurologybook.com/es/about-us/"><i class="fa fa-angle-right pr-1"></i>Sobre Nosotros</a>
                    </li>
                    <li class="nav-item nav-item-anim-icon d-none d-md-block">
                      <a class="nav-link" href="https://beta.pediatricurologybook.com/es/contact-us/"><i class="fa fa-angle-right pr-1"></i>Contacta con Nosotros</a>
                    </li>
                    <li class="nav-item dropdown nav-item-left-border d-block nav-item-left-border-remove nav-item-left-border-md-show">
                      
                      <a class="nav-link" href="#" role="button" id="dropdown-language" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
                        <i class="fas fa-globe-americas"></i> Español
                        <i class="fas fa-angle-down"></i>
                      </a>
                      <div class="dropdown-menu" aria-labelledby="dropdown-language">
                        
                          
                          
                          
                          
                          <a class="dropdown-item" href="https://beta.pediatricurologybook.com/book/chapters/03-20_voiding-dysfunction/">English</a>
                          
                        
                          
                            
                          
                          
                          
                          
                          <a class="dropdown-item" href="https://beta.pediatricurologybook.com/zh/book/chapters/03-20_voiding-dysfunction/">简体中文</a>
                          
                        
                          
                          
                          
                          
                          <a class="dropdown-item" href="https://beta.pediatricurologybook.com/pt/book/chapters/03-20_voiding-dysfunction/">Português</a>
                          
                        
                      </div>
                    </li>
                  </ul>
                </nav>
                <div class="header-nav-features header-nav-features-no-border header-nav-features-md-show-border d-none d-md-inline-flex">
                    <div class="simple-search input-group w-auto">
                      <input class="form-control text-1" id="search-input" name="q" type="text" value="" placeholder="Buscar...">
                      <span class="input-group-btn">
                        <button class="btn" type="submit">
                          <i class="fa fa-search"></i>
                        </button>
                      </span>
                      <ul id="search-results">
                      </ul>
                    </div>
                </div>
              </div>
              <div class="header-row">
                <div class="header-nav pt-1">
                  <div class="header-nav-main header-nav-main-effect-1 header-nav-main-sub-effect-1">
                    <nav class="collapse">
                      <ul class="nav nav-pills" id="mainNav">
                        <li><a href="https://beta.pediatricurologybook.com/es/"><i class="fas fa-home pr-1"></i>Inicio</a></li>
                        <li><a href="https://beta.pediatricurologybook.com/es/book/"><i class="fas fa-book pr-1"></i>Leer el Libro</a></li>
                        <li><a href="https://beta.pediatricurologybook.com/es/editors/"><i class="fas fa-pen-fancy pr-1"></i>Editores</a></li>
                        <li><a href="https://beta.pediatricurologybook.com/es/contributors/"><i class="fas fa-code-branch pr-1"></i>Autores</a></li>
                        <li><a href="https://beta.pediatricurologybook.com/es/sponsors/"><i class="fas fa-user-md pr-1"></i>Patrocinadores</a></li>
                      </ul>
                    </nav>
                  </div> <!-- end header-nav-main -->
                  <button class="btn header-btn-collapse-nav" data-toggle="collapse" data-target=".header-nav-main nav">
                      <i class="fas fa-bars"></i>
                  </button>
                </div> <!-- end header-nav -->
              </div> <!-- end header-row -->
            </div> <!-- end header-column -->
          </div> <!-- end header-row -->
        </div> <!-- end header-container -->
      </div> <!-- end header-body -->
    </header>
        
    
    <div role="main" class="main">
      <section class="page-header page-header-modern bg-color-primary page-header-md">
        <div class="container">
          <div class="row">
            <div class="col-md-8 order-2 order-md-1 align-self-center p-static">
              <h1>20: Voiding Dysfunction</h1>
            </div>
            
            <div class="col-md-4 order-1 order-md-2 align-self-center">
              <ul class="breadcrumb d-block text-md-right breadcrumb-light">
              
                <li><a href="https://beta.pediatricurologybook.com/es/">Home</a></li>
              
                <li><a href="https://beta.pediatricurologybook.com/es/book/">Book</a></li>
              
                <li class="active"><a href="https://beta.pediatricurologybook.com/es/book/#section-3"> 3</a></li>
              </ul>
            </div>
          </div>
        </div>
      </section>
      <div class="container chapter chapter-03-20">
        <div class="row">
          <div class="col-lg-3 order-2 order-lg-1 mt-4 mt-lg-0 chapter-toc">
            <aside class="sidebar">
              <h5 class="font-weight-bold no_toc">Contenido del Capítulo</h5>
    
            <ul class="nav nav-list flex-column mb-5">
<li class="nav-item toc-h2"><a href="#introduction">Introduction</a></li>
<li class="nav-item toc-h2"><a href="#genetics">Genetics</a></li>
<li class="nav-item toc-h2"><a href="#epidemiology">Epidemiology</a>
<ul>
<li class="nav-item toc-h3"><a href="#neuropsychiatric-comorbidity">Neuropsychiatric Comorbidity</a></li>
</ul>
</li>
<li class="nav-item toc-h2"><a href="#evaluation">Evaluation</a>
<ul>
<li class="nav-item toc-h3"><a href="#history">History</a></li>
<li class="nav-item toc-h3"><a href="#physical-examination">Physical Examination</a></li>
<li class="nav-item toc-h3"><a href="#diagnostic-testing">Diagnostic Testing</a>
<ul>
<li class="nav-item toc-h4"><a href="#urinalysis">Urinalysis</a></li>
<li class="nav-item toc-h4"><a href="#post-void-residual">Post Void Residual</a></li>
<li class="nav-item toc-h4"><a href="#uroflowemg">Uroflow/EMG</a></li>
<li class="nav-item toc-h4"><a href="#renal-and-bladder-ultrasonography">Renal and Bladder Ultrasonography</a></li>
<li class="nav-item toc-h4"><a href="#kub-and-ap-lateral-of-spine">KUB and AP Lateral of Spine</a></li>
<li class="nav-item toc-h4"><a href="#voiding-cystourethrography">Voiding Cystourethrography</a></li>
<li class="nav-item toc-h4"><a href="#mri-of-spine">MRI of Spine</a></li>
<li class="nav-item toc-h4"><a href="#urodynamics">Urodynamics</a></li>
</ul>
</li>
</ul>
</li>
<li class="nav-item toc-h2"><a href="#treatment-options">Treatment Options</a>
<ul>
<li class="nav-item toc-h3"><a href="#urotherapy">Urotherapy</a></li>
<li class="nav-item toc-h3"><a href="#bowel-management">Bowel Management</a></li>
<li class="nav-item toc-h3"><a href="#pharmacological">Pharmacological</a>
<ul>
<li class="nav-item toc-h4"><a href="#anticholinergics">Anticholinergics</a></li>
<li class="nav-item toc-h4"><a href="#alpha-blockers">Alpha Blockers</a></li>
<li class="nav-item toc-h4"><a href="#beta-3-agonists">Beta-3 Agonists</a></li>
<li class="nav-item toc-h4"><a href="#other-medications">Other Medications</a></li>
<li class="nav-item toc-h4"><a href="#ssris-and-snris">SSRIs and SNRIs</a></li>
</ul>
</li>
<li class="nav-item toc-h3"><a href="#electrical-stimulation">Electrical Stimulation</a>
<ul>
<li class="nav-item toc-h4"><a href="#sacral-neurostimulation">Sacral Neurostimulation</a></li>
<li class="nav-item toc-h4"><a href="#parasacral-stimulation-with-transcutaneous-electrical-nerve-stimulation">Parasacral Stimulation with Transcutaneous Electrical Nerve Stimulation</a></li>
<li class="nav-item toc-h4"><a href="#tibial-peripheral-nerve-stimulation">Tibial Peripheral Nerve Stimulation</a></li>
</ul>
</li>
<li class="nav-item toc-h3"><a href="#surgical-options">Surgical Options</a>
<ul>
<li class="nav-item toc-h4"><a href="#botulinum-toxin-a">Botulinum Toxin A</a></li>
</ul>
</li>
<li class="nav-item toc-h3"><a href="#biofeedback">Biofeedback</a></li>
</ul>
</li>
<li class="nav-item toc-h2"><a href="#disorders">Disorders</a>
<ul>
<li class="nav-item toc-h3"><a href="#overactive-bladder">Overactive Bladder</a>
<ul>
<li class="nav-item toc-h4"><a href="#evaluation-and-diagnosis">Evaluation and Diagnosis</a></li>
<li class="nav-item toc-h4"><a href="#treatment-options-and-pitfalls">Treatment Options and Pitfalls</a></li>
</ul>
</li>
<li class="nav-item toc-h3"><a href="#dysfunctional-voiding">Dysfunctional Voiding</a>
<ul>
<li class="nav-item toc-h4"><a href="#evaluation-and-diagnosis-1">Evaluation and Diagnosis</a></li>
<li class="nav-item toc-h4"><a href="#treatment-options-and-their-pitfalls">Treatment Options and Their Pitfalls</a></li>
</ul>
</li>
<li class="nav-item toc-h3"><a href="#bulbar-urethritisurethrorrhagia">Bulbar Urethritis/Urethrorrhagia</a>
<ul>
<li class="nav-item toc-h4"><a href="#evaluation-and-diagnosis-2">Evaluation and Diagnosis</a></li>
</ul>
</li>
<li class="nav-item toc-h3"><a href="#underactive-bladder">Underactive Bladder</a>
<ul>
<li class="nav-item toc-h4"><a href="#evaluation-and-diagnosis-3">Evaluation and Diagnosis</a></li>
<li class="nav-item toc-h4"><a href="#treatment-options-and-pitfalls-1">Treatment Options and Pitfalls</a></li>
</ul>
</li>
<li class="nav-item toc-h3"><a href="#pollakiuria">Pollakiuria</a>
<ul>
<li class="nav-item toc-h4"><a href="#evaluation-and-diagnosis-4">Evaluation and Diagnosis</a></li>
<li class="nav-item toc-h4"><a href="#treatment-options-and-pitfalls-2">Treatment Options and Pitfalls</a></li>
</ul>
</li>
<li class="nav-item toc-h3"><a href="#giggle-incontinence">Giggle Incontinence</a>
<ul>
<li class="nav-item toc-h4"><a href="#evaluation-and-diagnosis-5">Evaluation and Diagnosis</a></li>
<li class="nav-item toc-h4"><a href="#treatment-options-and-pitfalls-3">Treatment Options and Pitfalls</a></li>
</ul>
</li>
<li class="nav-item toc-h3"><a href="#vaginal-voiding">Vaginal Voiding</a>
<ul>
<li class="nav-item toc-h4"><a href="#evaluation-and-diagnosis-6">Evaluation and Diagnosis</a></li>
<li class="nav-item toc-h4"><a href="#treatment-options-and-pitfalls-4">Treatment Options and Pitfalls</a></li>
</ul>
</li>
<li class="nav-item toc-h3"><a href="#stress-incontinence">Stress Incontinence</a>
<ul>
<li class="nav-item toc-h4"><a href="#evaluation-and-diagnosis-7">Evaluation and Diagnosis</a></li>
<li class="nav-item toc-h4"><a href="#treatment-options-and-pitfalls-5">Treatment Options and Pitfalls</a></li>
</ul>
</li>
</ul>
</li>
<li class="nav-item toc-h2"><a href="#key-points">Key Points</a></li>
<li class="nav-item toc-h2"><a href="#conclusions">Conclusions</a></li>
<li class="nav-item toc-h2"><a href="#references">References</a></li>
</ul>
            
            </aside>
          </div>
          <div class="col-lg-9 order-1 order-lg-2 chapter-body">
            <p class="time-to-read"><i class="fas fa-info pr-2"></i><em>Le tomará aproximadamente 39 minutos leer este capítulo.</em></p>
                
            <p class="attribution">By <strong class="author-names">Israel Franco, MD</strong>,<sup>1</sup> <strong class="author-names">Sarah Lambert, MD</strong>,<sup>1</sup> &amp; <strong class="author-names">Anka J. Nieuwhof-Leppink, PhD</strong><sup>2</sup><br>
<em class="author-title"><sup>1</sup> Yale School of Medicine, New Haven, CT, USA</em><br>
<em class="author-title"><sup>2</sup> Department of Medical Psychology and Social Work and Urology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, the Netherlands</em></p>

<h2 id="introduction">
<a class="anchor" href="#introduction" aria-hidden="true"><span class="octicon octicon-link"></span></a>Introduction</h2>

<p class="drop-caps">Lower urinary tract symptoms (<abbr title="lower urinary tract symptoms">LUTS</abbr>), bladder and bowel dysfunction (<abbr title="bowel and bladder dysfunction">BBD</abbr>) or dysfunctional elimination syndrome are all terms that describe what are the common array of symptoms which range from overactive bladder syndrome (<abbr title="overactive bladder">OAB</abbr>), voiding postponement, stress incontinence, giggle incontinence to dysfunctional voiding aside from others.<a class="citation" href="#ruarte1987a"><span style="vertical-align: super">1</span></a> The impact of daytime wetting in children can be quite profound—with social, emotional and behavioral effect on daily life.<a class="citation" href="#landgraf2004a"><span style="vertical-align: super">2</span></a> From our understanding of <abbr title="overactive bladder">OAB</abbr> we know that if it continues over a prolonged period of time, we will see thickening of the bladder wall, which can have an lifelong impact. As patients become older, the consequences become more profound and require more of an effort to correct.<a class="citation" href="#fitzgerald2006a"><span style="vertical-align: super">3,4</span></a></p>

<p>From a pediatric urology perspective, the child with <abbr title="overactive bladder">OAB</abbr> is likely to becoming an adult <abbr title="overactive bladder">OAB</abbr> problems. This correlation has been seen in two published reports. In the first study Fitzgerald et al<a class="citation" href="#fitzgerald2006a"><span style="vertical-align: super">3</span></a> revealed that frequent daytime voiding in childhood correlated with adult urgency, and a correlation existed between childhood and adult nocturia. Childhood daytime incontinence and nocturnal enuresis were associated with a more than 2 fold increased association with adult urge incontinence. In addition, history of childhood urinary tract infection (<abbr title="urinary tract infection">UTI</abbr>) correlated with adult <abbr title="urinary tract infection">UTI</abbr>. In another study by Minassian <em>et al</em> involving 170 adult women they found that there was a higher prevalence of childhood voiding dysfunction in women who had urinary frequency, urgency, and stress or urge incontinence.<a class="citation" href="#minassian2006a"><span style="vertical-align: super">4</span></a> They also noted that symptomatic patients had a greater likelihood of higher <abbr title="body mass index">BMI</abbr>. The trend has been to reassure parents that these problems are self-limiting and will resolve as the child matures. It appears that spontaneous resolution may not always occur and some children as they mature are better at compensating for their problems and eventually fail to follow up. A better understanding of the potential causes of childhood <abbr title="overactive bladder">OAB</abbr> can prevent undue problems in adulthood and make many children, parents and teachers much happier.</p>

<h2 id="genetics">
<a class="anchor" href="#genetics" aria-hidden="true"><span class="octicon octicon-link"></span></a>Genetics</h2>

<p>Increasing evidence exists that genetic factors have a major role in urinary incontinence. Children of parents that have <abbr title="overactive bladder">OAB</abbr> and/or underlying psychiatric problems tend to be more refractory to conventional treatments of <abbr title="overactive bladder">OAB</abbr>.<a class="citation" href="#fitzgerald2006a"><span style="vertical-align: super">3,5</span></a> These findings have been corroborated by Labrie <em>et al</em>, whose research shows that mothers of children with <abbr title="overactive bladder">OAB</abbr> or dysfunctional voiding are more likely to have similar symptoms in childhood than mothers of children without <abbr title="lower urinary tract">LUT</abbr> symptoms (28.9% vs 16.3% p&lt;0.02, respectively).<a class="citation" href="#labrie2010a"><span style="vertical-align: super">5</span></a> Fathers of children with <abbr title="lower urinary tract">LUT</abbr> symptoms were more likely to have had delayed resolution of their nocturnal enuresis (6% and 6.5% boys and girls respectively) and also fathers who had daytime incontinence had a statistically significant rate of incontinence as children 9.25% vs 4.6% (p&lt;0.0001).<a class="citation" href="#labrie2010a"><span style="vertical-align: super">5</span></a> Adult data can be used as a proxy for children. Looking at the data available, some studies that indicate a genetic predisposition to <abbr title="lower urinary tract symptoms">LUTS</abbr> for some patients. A commonly used methodology to ascertain the importance of genetic influence is the use of twin studies. A Swedish study involving over 25000 twins revealed evidence of a genetic link for susceptibility to urinary incontinence, frequency and nocturia in women.<a class="citation" href="#wennberg2011a"><span style="vertical-align: super">6</span></a> There was insufficient data in male patients to make any conclusions. On the other hand, in a study looking at a metanalysis of candidate polymorphism/genes in men they found five genes ACE, ELAC2, GSTM1, TERT, and VDR. The heterogeneity was high in three of these meta-analyses. The rs731236 variant of the <a href="https://www-sciencedirect-com.yale.idm.oclc.org/topics/medicine-and-dentistry/vitamin-d-receptor">vitamin D receptor</a> had a protective effect for <abbr title="lower urinary tract symptoms">LUTS</abbr> (odds ratio: 0.64; 95% confidence interval, 0.49–0.83) with moderate heterogeneity (I2 = 27.2%).<a class="citation" href="#cartwright2014a"><span style="vertical-align: super">7</span></a></p>

<p>When looking at the psychiatric literature there is a large number of studies linking psychological conditions and <abbr title="lower urinary tract symptoms">LUTS</abbr>. The association of urinary incontinence and psychological well-being in adults has also been noted by Botlero <em>et al</em>.<a class="citation" href="#botlero-a"><span style="vertical-align: super">8</span></a> Major depression can predict the onset of urinary incontinence in women in an at-risk population based sample.<a class="citation" href="#melville2009a"><span style="vertical-align: super">9</span></a> One study found increased rates of enuresis in adult bipolar disorder (18%).<a class="citation" href="#henin2007a"><span style="vertical-align: super">10</span></a> An association with panic disorder and interstitial cystitis has also been described.<a class="citation" href="#weissman2004a"><span style="vertical-align: super">11</span></a> Day wetting also was found to be a premorbid developmental marker for schizophrenia (<abbr title="schizophrenia">SCZ</abbr>).<a class="citation" href="#hyde2008a"><span style="vertical-align: super">12</span></a> The authors found that patients with <abbr title="schizophrenia">SCZ</abbr> had higher rates of childhood enuresis (21%) compared with siblings (11%) or control patients (7%), and the relative risk for enuresis was increased in siblings. Patients with enuresis performed worse on two frontal lobe cognitive tests (letter fluency and category fluency) as compared with non-enuretic patients. Notably cerebral defects associated with these disorders tend to cluster around the anterior cingulate cortex (<abbr title="anterior cingulate cortex">ACC</abbr>) and prefrontal cortex (<abbr title="prefrontal cortex">PFC</abbr>) exactly where defects are being seen in patients with urgency and urge incontinence on fMRI.<a class="citation" href="#fowler2010a"><span style="vertical-align: super">13,14</span></a></p>

<h2 id="epidemiology">
<a class="anchor" href="#epidemiology" aria-hidden="true"><span class="octicon octicon-link"></span></a>Epidemiology</h2>

<p>The prevalence of daytime incontinence varies widely from study to study. By 7 years of age, daytime incontinence rate ranges from 4.9 to 11.7%.<a class="citation" href="#hansen1997a"><span style="vertical-align: super">15,16</span></a> At 11–12 years of age, prevalence rate ranges between 0.8% and 12.5%.<a class="citation" href="#lee2000a"><span style="vertical-align: super">17,18,19,20,21</span></a> A meta-analysis of these 3 studies was performed resulting in an overall prevalence of 6.4%. The most important study shedding light on a continual basis is the English <abbr title="Avon Longitudinal Study of Parents and Children">ALSPAC</abbr> longitudinal study which found the following trajectories for daytime incontinence over the age range 4.5-9.5 years:<a class="citation" href="#heron2008a"><span style="vertical-align: super">22</span></a></p>

<p>i. Normative (86.2%); dry by 4.5 years
ii. Delayed (6.9%); steadily decreasing probability of daytime incontinence from 80% at 4.5 years of age to &lt; 10% at 9.5 years of age
iii. Persistent (3.7%); probability of daytime incontinence &gt; 80% until 7.5 years of age with steady reduction to 60% at 9.5 years of age
iv. Relapsing (3.2%); probability of daytime incontinence &lt;10% at 5.5 years of age increasing to 60% at 6.5 years with slow decline thereafter.</p>

<p>There was no gender difference in the delayed group but girls outnumbered boys in the persistent and relapsing groups. A study by Stone <em>et al</em> that evaluated children with persistent urinary incontinence who underwent urodynamic investigation and imaging of their spines revealed that, if extrapolated to 18 years of age, up to 33% of the children that were wetting at 10 years of age were likely to persist with some form of urinary symptoms.<a class="citation" href="#stone2010a"><span style="vertical-align: super">23</span></a></p>

<h3 id="neuropsychiatric-comorbidity">
<a class="anchor" href="#neuropsychiatric-comorbidity" aria-hidden="true"><span class="octicon octicon-link"></span></a>Neuropsychiatric Comorbidity</h3>

<p>Children with elimination disorders have an increased rate of coexistent behavioral and psychological disorders; approximately 20–40% of children with daytime urinary incontinence are affected by behavioral disorders.<a class="citation" href="#tekgul-a"><span style="vertical-align: super">24,25,26</span></a> In a large epidemiological study of 8213 children aged 7.5–9 years, children with daytime wetting had significantly increased rates of psychological conditions, especially separation anxiety (11.4%), attention deficit hyperactivity disorder (<abbr title="attention deficit hyperactivity disorder">ADHD</abbr>) (24.8%), oppositional behavior (10.9%), and conduct problems (11.8%).<a class="citation" href="#joinson2006a"><span style="vertical-align: super">27</span></a> In the same cohort, 10,000 children aged 4–9 years were evaluated; delayed development, difficult temperament, and maternal depression/anxiety were associated with daytime wetting and soiling.<a class="citation" href="#joinson2008a"><span style="vertical-align: super">28</span></a> In another population-based study that included 2856 children, the incidence of incontinence was 16.9% within the previous 6 months.<a class="citation" href="#sureshkumar2009a"><span style="vertical-align: super">29</span></a> In a retrospective study of patients with <abbr title="attention deficit hyperactivity disorder">ADHD</abbr>, 20.9% wet at night and 6.5% wet during the day. The odds ratios were 2.7 and 4.5, respectively, which demonstrates a non-specific association of <abbr title="attention deficit hyperactivity disorder">ADHD</abbr> with nighttime and daytime wetting.<a class="citation" href="#robson1997a"><span style="vertical-align: super">30</span></a> Of the possible gastrointestinal elimination disorders, children with fecal incontinence (or encopresis) had the highest rates of comorbid behavioral disorders: 30–50% of all children had clinically relevant behavioral disturbances.<a class="citation" href="#tekgul-a"><span style="vertical-align: super">24,25</span></a> In an epidemiological study of over 8242 children, those who were 7- to 8-years of age had a wide range of coexistent disorders (<abbr title="Diagnostic and Statistical Manual of Mental Disorders">DSM</abbr>-IV) including separation anxiety (4.3%), social phobias (1.7%), specific phobias (4.3%), generalized anxiety (3.4%), depressive disorders (2.6%), <abbr title="attention deficit hyperactivity disorder">ADHD</abbr> (9.2%), and oppositional defiant behavior (11.9%). A previous study found that patients described as having psychoneuroticism were less likely to respond to treatment of detrusor instability than those who had no form of psychoneuroticism. Most good responders and one third of non-responders were free of psychiatric issues.<a class="citation" href="#moore1990a"><span style="vertical-align: super">31</span></a> Of importance, 25% of the patients in this study had irritable bowel syndrome symptoms.</p>

<h2 id="evaluation">
<a class="anchor" href="#evaluation" aria-hidden="true"><span class="octicon octicon-link"></span></a>Evaluation</h2>

<h3 id="history">
<a class="anchor" href="#history" aria-hidden="true"><span class="octicon octicon-link"></span></a>History</h3>

<p>Evaluation of the child with <abbr title="bowel and bladder dysfunction">BBD</abbr> begins with detailed history and physical examination. A clear history helps determine prevailing symptomatology and when the symptoms tend to occur. Generally, it is best to try to obtain the pertinent history from the child if they are cooperative. When obtaining the history from the child is not possible, there may be no choice but to obtain it from the parents. Signs of urgency such as crossing the legs, running to the bathroom, grabbing the penis, rubbing the clitoris, squatting and sitting on the heels (Vincent’s curtsy) are all signs of urgency. Maintenance of a voiding diary is critical. Urinary frequency is another manifestation of <abbr title="overactive bladder">OAB</abbr> and quantifying the amount and number of times the patient voids is useful in determining if there is true frequency. Urinary urge incontinence is a classic hallmark of overactive bladder. The time at which incontinence occurs should be documented to help identify any association with the bowel. It is not uncommon in children with large stool burdens to have urgency and urge incontinence after a meal. This is most likely due to stimulation of colonic contractions by the gastrocolic reflex. It is well understood that there is cross talk occurring in the spinal cord between the colon and the bladder.<a class="citation" href="#warne2381a"><span style="vertical-align: super">32,33,34,35</span></a> This may trigger bladder contractions or at least lead to symptoms of urgency. Post void dribbling is a sign of either incomplete relaxation of the whole sphincter complex or the external sphincter. It is common in children with dysfunctional voiding. Also commonly seen in dysfunctional voiding patients is dysuria or urethrorrhagia that is not associated with infection but rather due to dyssynergic voiding.<a class="citation" href="#herz2005a"><span style="vertical-align: super">33</span></a></p>

<p>Internal sphincter dyssynergia has been associated with dizziness and autonomic dysfunction (hypotension on standing without concomitant increase in heart rate) for both males and females when patients are asked if they get dizzy on standing.<a class="citation" href="#franco2016a"><span style="vertical-align: super">36</span></a></p>

<p>A thorough history of the patient’s bowel habits should be obtained from the patient directly. Many parents are not cognizant of the true nature of their children's bowel movements and many will report that their children's bowel movements are normal while the children will steadfastly contradict them. Documentation of the size and nature of the bowel movements should be obtained. Use of a diagram is quite beneficial and it facilitates communication with the child.<a class="citation" href="#lewis1997a"><span style="vertical-align: super">37</span></a> It is important to note if the bowel movements are painful or associated with rectal bleeding. Large massive bowel movements are usually an indicator of infrequent bowel movements. Pain or rectal bleeding can be associated with external sphincter dyssynergia. Patients who have diarrhea or symptoms of colitis can also have issues with overactive bladder. Chronic periumbilical pain is another sign that there is a problem with constipation or issues with serotonin homeostasis in the gut. Many children will complain of this pain and once a bowel regimen is instituted the pain goes away.</p>

<p>A standardized questionnaire should be used to evaluate patients when first seen and on follow up. There are 2 commonly used questionnaires that have been validated for children, the first is the <abbr title="Dysfunctional Voiding Symptom Scoree">DVSS</abbr> and the other is the Vancouver Scale.<a class="citation" href="#farhat2000a"><span style="vertical-align: super">38,39</span></a> Additionally, there is a questionnaire that evaluates the psychiatric makeup of the child and is quite useful to quickly screen for underlying attention, hyperactivity, depression and anxiety issues in children which are commonly associated with <abbr title="lower urinary tract symptoms">LUTS</abbr>.<a class="citation" href="#hoecke2007a"><span style="vertical-align: super">40</span></a></p>

<h3 id="physical-examination">
<a class="anchor" href="#physical-examination" aria-hidden="true"><span class="octicon octicon-link"></span></a>Physical Examination</h3>

<p>Physical examination is helpful in evaluation and can be very revealing. Examination of the abdomen is critical in determining whether there is palpable stool in the colon. Palpation of the left lower quadrant up to the left upper quadrant typically will yield large amounts of stool present in these abdomens. In many cases the parents may deny issues with their bowels. Gaseous distention of the colon is just as troublesome and should be noted since this can lead to the same problems as constipation.</p>

<p>Examination of the back will typically reveal a normal appearing back and anocutaneous folds. The rare instance of flattening of the buttocks or abnormal creasing at the <abbr title="suicidal ideation">SI</abbr> joint is indicative of a sacral anomaly (<a href="#figure-1" class="figure-link">Figure 1</a>) and (<a href="#figure-2" class="figure-link">Figure 2</a>) Observing the child walk can also help identify a potential neurologic problem if the child performs toe walking. High arched feet are another potential clue to some form of neurologic condition. Low lying sacral dimples are typically not of concern. Only dimples that are associated with tuffs of hair or a placed higher up on the back are of concern and should be evaluated with an <abbr title="magnetic resonance imaging">MRI</abbr> of the lumbar-sacral spine.</p>

<p><img src="https://beta.pediatricurologybook.com/assets/figures/figure-20-1.jpeg" alt="Figure 1" class="float-start img-fluid"><br>
<strong id="figure-1" class="figure-number">Figure 1</strong> Abnormal sacral cleft associated with tethered cord.</p>

<p><img src="https://beta.pediatricurologybook.com/assets/figures/figure-20-2.jpeg" alt="Figure 2" class="float-start img-fluid"><br>
<strong id="figure-2" class="figure-number">Figure 2</strong> Parasacral appendage associated with cord thethering.</p>

<h3 id="diagnostic-testing">
<a class="anchor" href="#diagnostic-testing" aria-hidden="true"><span class="octicon octicon-link"></span></a>Diagnostic Testing</h3>

<p>Below we discuss the diagnostic tests we perform in the order in which we perform them to optimize our management and minimize invasive testing in patients.</p>

<h4 id="urinalysis">
<a class="anchor" href="#urinalysis" aria-hidden="true"><span class="octicon octicon-link"></span></a>Urinalysis</h4>

<p>The first and most important clinical test that should be performed in all children that present with <abbr title="bowel and bladder dysfunction">BBD</abbr> is the urinalysis. A simple urinalysis should help determine if the symptoms are due to infection or <abbr title="bowel and bladder dysfunction">BBD</abbr>. It is not uncommon to see microhematuria in patients that have dyssynergic voiding which is commonly associated with <abbr title="bowel and bladder dysfunction">BBD</abbr>.</p>

<h4 id="post-void-residual">
<a class="anchor" href="#post-void-residual" aria-hidden="true"><span class="octicon octicon-link"></span></a>Post Void Residual</h4>

<p>A <abbr title="post-void residual">PVR</abbr> should be done on all patients seen for <abbr title="lower urinary tract symptoms">LUTS</abbr> and <abbr title="dysfunctional voiding">DV</abbr>. This is the most important piece of information that you have to go on in the early stages of the evaluation and can give you further immediate insight into the potential issues that need to be addressed. Elevated residuals can be associated with recurrent <abbr title="urinary tract infections">UTIs</abbr> or frequent voiding, while low <abbr title="post-void residual">PVR</abbr> can be also associated with frequency, but the underlying etiology of the frequency will be different.</p>

<p>A device capable of providing a real image of the bladder is preferred over a device that gives a representative image. This is valuable since one can also measure rectal diameter. Rectal diameters in excess of 4 cm are associated with <abbr title="bowel and bladder dysfunction">BBD</abbr> and studies have shown correction of this dilation is associated with improvements in symptoms.</p>

<h4 id="uroflowemg">
<a class="anchor" href="#uroflowemg" aria-hidden="true"><span class="octicon octicon-link"></span></a>Uroflow/<abbr title="electromyography">EMG</abbr>
</h4>

<p>Uroflowmetry is an important tool in helping to determine if the child voids abnormally. The use of the 5 classic curves, bell, the tower or hypervoider, the staccato, interrupted and the plateau curve is in the process of being supplanted by a modified system that relies on whether the curve is smooth or fractionated and a flow index. The flow index is volume agnostic so therefore can be used to compare flows at all volumes and across multiple ages.<a class="citation" href="#franco2016b"><span style="vertical-align: super">41,42,43</span></a> Additionally flow indexes are a measure of voiding efficiency which is much more accurate representation of flow than shape descriptions.</p>

<p>The use of the uroflow is further augmented by the concomitant use of an <abbr title="electromyography">EMG</abbr> of the perineal muscles. Utilizing the perineal <abbr title="electromyography">EMG</abbr> allows us to determine if the child is voiding with external sphincter dyssynergia (increased perineal muscle activity) and to diagnose internal sphincter dyssynergia based on lag time and the shape of the flow curve (typically plateau or Flow index &lt;=0.7).<a class="citation" href="#combs2005a"><span style="vertical-align: super">44</span></a></p>

<h4 id="renal-and-bladder-ultrasonography">
<a class="anchor" href="#renal-and-bladder-ultrasonography" aria-hidden="true"><span class="octicon octicon-link"></span></a>Renal and Bladder Ultrasonography</h4>

<p>Renal-bladder ultrasound is not essential for children with <abbr title="lower urinary tract symptoms">LUTS</abbr> not associated with infection. On the other hand, a patient with repeat infections should have the upper tracts examined to look for size discrepancies and hydronephrosis which could be indicative of reflux or consequences thereof. In patients with persistent incontinence an ultrasound is useful to rule out a duplication of the kidney associated with an ectopic ureter. Dilation of a ureter may be another clue to suggest an ectopic ureter. In patients with obstructive voiding, the bladder ultrasound is helpful in identifying the presence of an obstructing ureterocele. Bladder wall thickening can be discerned from the ultrasound and is a useful indicator of obstruction or overactivity.</p>

<h4 id="kub-and-ap-lateral-of-spine">
<a class="anchor" href="#kub-and-ap-lateral-of-spine" aria-hidden="true"><span class="octicon octicon-link"></span></a><abbr title="kidney-ureter bladder">KUB</abbr> and <abbr title="anterior posterior">AP</abbr> Lateral of Spine</h4>

<p>In some children where body habitus makes palpation of stool unreliable, it may be necessary to consider <abbr title="kidney-ureter bladder">KUB</abbr> to evaluate the colonic stool burden or to assess progress with a bowel regimen. If a <abbr title="kidney-ureter bladder">KUB</abbr> is performed, it is reasonable to consider an <abbr title="anterior posterior">AP</abbr> and lateral film of the sacrum to confirm that there are no sacral anomalies (<a href="#figure-3" class="figure-link">Figure 3</a>) In some children, a <abbr title="kidney-ureter bladder">KUB</abbr> can be inadequate to verify the spine is normal due to overlying stool obscuring the sacrum.</p>

<p><img src="https://beta.pediatricurologybook.com/assets/figures/figure-20-3.jpeg" alt="Figure 3" class="float-start img-fluid"><br>
<strong id="figure-3" class="figure-number">Figure 3</strong> Lateral fim of spine clearly shows sacral segments that would not be visible due to large stool burden in this patient.</p>

<h4 id="voiding-cystourethrography">
<a class="anchor" href="#voiding-cystourethrography" aria-hidden="true"><span class="octicon octicon-link"></span></a>Voiding Cystourethrography</h4>

<p>A well-tempered <abbr title="voiding cystourethrogram">VCUG</abbr> provides a tremendous amount of information on the dynamics of voiding in addition to the presence or absence of reflux, ectopic ureters or valves. The bladder neck can be seen opening and the external sphincter can also be seen as it opens and closes. The presence of the spinning top urethra is a classic example of external sphincter dyssynergia (<a href="#figure-4" class="figure-link">Figure 4</a>) A <abbr title="voiding cystourethrogram">VCUG</abbr> is not indicated in all patients with <abbr title="lower urinary tract symptoms">LUTS</abbr>. A <abbr title="voiding cystourethrogram">VCUG</abbr> should be obtained in refractory cases to further delineate the dynamics of voiding and confirm no anatomic problem is missed.</p>

<p><img src="https://beta.pediatricurologybook.com/assets/figures/figure-20-4.jpeg" alt="Figure 4" class="float-start img-fluid"><br>
<strong id="figure-4" class="figure-number">Figure 4</strong> Spinning top urethra in female with reflux and recurrent <abbr title="urinary tract infections">UTIs</abbr>.</p>

<h4 id="mri-of-spine">
<a class="anchor" href="#mri-of-spine" aria-hidden="true"><span class="octicon octicon-link"></span></a><abbr title="magnetic resonance imaging">MRI</abbr> of Spine</h4>

<p>Sacral imaging is indicated when the patient has an obvious lesion of the back, as previously mentioned in the physical examination section. In patients who have failed all treatment attempts and incontinence persists an <abbr title="magnetic resonance imaging">MRI</abbr> of the spine may also be indicated. We recommend the <abbr title="magnetic resonance imaging">MRI</abbr> be completed prior to urodynamics since detrusor overacitivity on urodynamics is not diagnostic of neurogenic bladder dysfunction. Therefore, the patient will need an <abbr title="magnetic resonance imaging">MRI</abbr> of spine regardless and best to proceed with the definitive test first. Occult tethered cord occurs very infrequently when there is no cutaneous stigmata.<a class="citation" href="#tuite2018a"><span style="vertical-align: super">45</span></a></p>

<h4 id="urodynamics">
<a class="anchor" href="#urodynamics" aria-hidden="true"><span class="octicon octicon-link"></span></a>Urodynamics</h4>

<p>In patients with <abbr title="lower urinary tract symptoms">LUTS</abbr>, urodynamic study often only confirms a thorough history that uninhibited contractions (<abbr title="uninhibited contraction">UIC</abbr>) are present. Bael <em>et al</em> justify this statement as they demonstrated there was no benefit to performing a urodynamic study in children with <abbr title="bowel and bladder dysfunction">BBD</abbr>.<a class="citation" href="#bael2008a"><span style="vertical-align: super">46</span></a> The presence of <abbr title="uninhibited contractions">UICs</abbr> does not rule in or out the presence of a neurologic lesion. The only finding of significance is the absence of a detrusor contraction already evident from the uroflow study demonstrating a poor flow curve. This is not to say that there is no indication to perform <abbr title="urodynamics">UDS</abbr> in children. In some instances, urodynamics are performed simultaneously with <abbr title="voiding cystourethrogram">VCUG</abbr>. In some cases, <abbr title="urodynamics">UDS</abbr> can help identify the source of the wetting especially when combined with fluoroscopy.</p>

<h2 id="treatment-options">
<a class="anchor" href="#treatment-options" aria-hidden="true"><span class="octicon octicon-link"></span></a>Treatment Options</h2>

<h3 id="urotherapy">
<a class="anchor" href="#urotherapy" aria-hidden="true"><span class="octicon octicon-link"></span></a>Urotherapy</h3>

<p>Urotherapy is an umbrella term for all non-surgical, non-pharmacological interventions for functional bladder and bowel problems in children and adolescents. It is the mainstay treatment for daytime urinary incontinence, as well as for nocturnal incontinence, functional constipation, and fecal incontinence.<a class="citation" href="#chang2017a"><span style="vertical-align: super">47,48</span></a></p>

<p>The goal of urotherapy is to normalize micturition and bowel pattern and to prevent further functional disturbances. A distinction is made between standard urotherapy and specific urotherapy. Three conditions must be met before urotherapy can start. First, a clear diagnosis of functional incontinence. Second, the child must be school-ready, when the child is too immature, he/she may not have the cognitive skills or motor abilities to understand and complete urotherapy. Third, a good psychosocial anamnesis as psychosocial or behavioral problems may also influence the effectiveness of therapy and may require psychiatric evaluation or family therapy.<a class="citation" href="#gontard2019a"><span style="vertical-align: super">49,50</span></a></p>

<p>Standard urotherapy consists of education and demystification, behavioral modification instructions, lifestyle advice regarding fluid intake, registration of voiding frequencies, voiding volumes and incontinence episodes, and support and encouragement to children and their parents.<a class="citation" href="#nieuwhof-leppink2021a"><span style="vertical-align: super">51</span></a> Urotherapy starts with an explanation of bladder and bowel function and dysfunction, explaining the causes of incontinence. Instructions should be given on correct fluid intake and regular voiding during the day. Instruction as to proper toilet posture should also be provided. A bladder diary should be kept for self-monitoring and motivation. The diary provides the child and parents insight into treatment progress. After explanation and instructions, the child practices at home for a maximum of three months. During this period, frequent counseling should be provided and progressed should be assessed frequently. These interval assessments can be done by telemedicine and/or regular visits to the clinic.</p>

<p>Constipation or urinary tract infections (<abbr title="urinary tract infections">UTIs</abbr>) should be addressed before urotherapy.<a class="citation" href="#chang2017a"><span style="vertical-align: super">47,48</span></a> As bowel and bladder dysfunction affect each other, urotherapy is less successful if bowel function and/or <abbr title="urinary tract infections">UTIs</abbr> are not addressed during treatment.<a class="citation" href="#nieuwhof-leppink2021a"><span style="vertical-align: super">51,52</span></a></p>

<p>Successful treatment is determined by the degree that the child and parents are satisfied with the results. Satisfaction and improved quality of life may be a reason to end treatment instead of endeavoring the best results. When treatment is not successful, it is important to identify the reason.</p>

<p>When the results of standard urotherapy are unsatisfactory, specific urotherapy is recommended. This therapy combines specialist interventions such as biofeedback of the pelvic floor, cognitive behavioral therapy, psychotherapy, neuro-stimulation, or clean intermittent catheterization).<a class="citation" href="#chang2017a"><span style="vertical-align: super">47,48,51,53</span></a> Specific urotherapy is tailored to the specific type of bladder-bowel dysfunction and is composed of specific programs for children with treatment-resistant symptoms. These programs help children to learn how to void, when to void, and how often to void. Repeated practice is necessary to habituate the new voiding behavior.<a class="citation" href="#macneily2016a"><span style="vertical-align: super">50</span></a></p>

<p>Children with behavioral problems require a tailored plan to the unique needs of the child.<a class="citation" href="#niemczyk2015a"><span style="vertical-align: super">54</span></a> For comorbidities and severe bladder-overactivity, medication may be necessary.<a class="citation" href="#chang2017a"><span style="vertical-align: super">47</span></a></p>

<p>Urotherapy is an effective treatment that achieves continence in 56% of children within a year, whilst the spontaneous cure rate of incontinence is 15% per year. Urotherapy addresses all aspects of incontinence, leading to the best clinical outcome. This includes somatic, psychosocial, and behavioral problems and quality of life.<a class="citation" href="#schafer2018a"><span style="vertical-align: super">55</span></a></p>

<h3 id="bowel-management">
<a class="anchor" href="#bowel-management" aria-hidden="true"><span class="octicon octicon-link"></span></a>Bowel Management</h3>

<p>Acute, simple constipation or colonic distention in many cases may be addressed by simply increasing hydration and/or adding juices high in sorbitol, such as prune, pear and apple juice along with pureed fruits and vegetables to the child’s normal diet. Barley malt extract or corn syrup can also be used to soften stools. Other dietary changes include decreasing excessive milk intake as calcium saponifies the stool and leads to hardening. In addition, no evidence currently exists supporting the use of prebiotic and/or probiotic dietary supplements as a treatment of constipation.<a class="citation" href="#medina-centeno2020a"><span style="vertical-align: super">56</span></a> Following the failure of dietary interventions, other treatment options include osmotic laxatives such as polyethylene glycol (0.7 g/kg body weight per day) lactulose, sorbitol or milk of magnesia (dose: 1–3 mL/kg body weight per day). No evidence exists that dietary fiber supplementation or biofeedback alone are effective interventions for constipation that requires medical treatment.<a class="citation" href="#medina-centeno2020a"><span style="vertical-align: super">56</span></a> Many patients require maintenance therapy in order to manage their ongoing constipation symptoms. In our own experience, osmotic agents are not as effective alone as when used in combination with senna laxatives or bisacodyl. The concern that senna alkaloids are habit forming or impair colonic motility is an ‘old wives tale’ and should be ignored: aggressive use of such medications is warranted in some children.<a class="citation" href="#wald2016a"><span style="vertical-align: super">57</span></a></p>

<p>Use of osmotic agents by themselves has been borne out by Bush <em>et al</em> whose research showed that polyethylene glycol 350 was not superior to placebo during a 1-month trial.<a class="citation" href="#bush2013a"><span style="vertical-align: super">58</span></a> Management of constipation can result in up to a 50% resolution in voiding symptoms or greater.<a class="citation" href="#loening-baucke1997a"><span style="vertical-align: super">59</span></a></p>

<h3 id="pharmacological">
<a class="anchor" href="#pharmacological" aria-hidden="true"><span class="octicon octicon-link"></span></a>Pharmacological</h3>

<h4 id="anticholinergics">
<a class="anchor" href="#anticholinergics" aria-hidden="true"><span class="octicon octicon-link"></span></a>Anticholinergics</h4>

<p>Anticholinergics, (also known as antimuscarinics) are typically used as first-line treatments of <abbr title="overactive bladder">OAB</abbr> in children whose symptoms have persisted following urotherapy. Currently, only three antimuscarinics (oxybutynin [<abbr title="Food and Drug Administration">FDA</abbr> and <abbr>EMA</abbr>] , Solfenacin [<abbr title="Food and Drug Administration">FDA</abbr> and <abbr>EMA</abbr>] and tolterodine [<abbr>EMA</abbr>]) have formally received approval for use in children. The clinical trials that have been performed in children (oxybutynin, solifenacin, darifenacin studies) have generally included patients with proven neurogenic voiding problems and have not investigated the effects of antimuscarinics on patients with non-neurogenic, or idiopathic <abbr title="lower urinary tract">LUT</abbr> symptoms. Data published in 2006 suggest that the therapeutic effects of antimuscarinics in patients considered to have no neurological deficits are mediated predominantly by interactions with the sensory/afferent limb of the reflex arc rather than with the efferent/motor side.<a class="citation" href="#finney2006a"><span style="vertical-align: super">60</span></a> Muscarinic receptors are found in urothelial cells, suburothelial cells of Cajal and on afferent nerves.<a class="citation" href="#andersson2011a"><span style="vertical-align: super">61</span></a> Antimuscarinics are active during the filling/storage phase of micturition when the cholinergic (efferent or motor) nerves are not active. Acetylcholine can be generated and released from the urothelium as a response to bladder filling/increases in tension and also might ‘leak’ from the cholinergic nerve terminals during bladder filling<a class="citation" href="#wein2006a"><span style="vertical-align: super">62</span></a> followed by binding to M<sub>2</sub> and M<sub>3</sub> receptors and might be a mechanism of overactivity in patients with bladder diseases..<a class="citation" href="#kullmann2008a"><span style="vertical-align: super">63</span></a></p>

<p>Five distinct subtypes of muscarinic, cholinergic receptors have been identified (M<sub>1</sub>–M<sub>5</sub>), and the bladder smooth muscle predominantly expresses two of these subtypes: M<sub>2</sub> (70–80%) and M<sub>3</sub> (20–30%). Activation of M<sub>3</sub> receptors has been demonstrated to evoke smooth muscle contraction, which is the primary stimulus for bladder contraction. M<sub>2</sub> and M<sub>3</sub> receptors have been postulated to be involved not only in activation of smooth muscle contraction by efferent nerves, but also in the activation of sensory/afferent nerves.<a class="citation" href="#andersson2011a"><span style="vertical-align: super">61</span></a> The activation of M<sub>2</sub> receptors in the urothelium might reverse the sympathetically mediated smooth muscle relaxation that enables the filling, or storage phase of the micturition cycle; although, activation of the M<sub>2</sub> receptors might cause smooth muscle contraction through other poorly understood mechanisms.<a class="citation" href="#andersson2004a"><span style="vertical-align: super">64</span></a></p>

<p>M<sub>1</sub> receptors are found in the brain, glands (such as salivary glands), and sympathetic ganglia. Activation of these receptors’ accounts for most of the adverse effects of antimuscarinic drugs. Dry mouth is the most common symptom. Constipation, gastroesophageal reflux, blurred vision, urinary retention and cognitive side effects can also occur; these symptoms are generally less bothersome in children. The potential for adverse cognitive effects and delirium does also exist in children but is generally limited to overdosing situations.<a class="citation" href="#ferrara2001a"><span style="vertical-align: super">65,66,67</span></a> In clinical trials in adults, quantitative electroencephalographic data suggests that oxybutynin has more effects on the <abbr title="central nervous system">CNS</abbr> than either trospium or tolterodine.<a class="citation" href="#todorova2001a"><span style="vertical-align: super">68,69</span></a></p>

<h4 id="alpha-blockers">
<a class="anchor" href="#alpha-blockers" aria-hidden="true"><span class="octicon octicon-link"></span></a>Alpha Blockers</h4>

<p>α-blockers (also known as α-adrenoceptor antagonists) on non-neuropathic voiding dysfunction was popularized by Austin <em>et al</em> to treat voiding dysfunction in children.<a class="citation" href="#austin1999a"><span style="vertical-align: super">70</span></a> These medications have been used in the management of patients with bladder-neck dysfunction and urinary retention, these agents are also useful in ameliorating the symptoms of urgency and urge incontinence in some children.<a class="citation" href="#franco-a"><span style="vertical-align: super">71</span></a> Studies in adults indicate that alpha blockers are effective in managing irritative symptoms due to stents and in older men with benign prostatic hyperplasia.<a class="citation" href="#dellis2014a"><span style="vertical-align: super">72,73</span></a> There is some evidence that alfuzosin reduced anal pressure at rest and during simulated evacuation in healthy and constipated women compared with placebo but did not improve bowel symptoms in constipated women.<a class="citation" href="#chakraborty2019a"><span style="vertical-align: super">74</span></a> In many patients, terazosin, a non-selective α-blocker, is the first-line drug for treatment of urgency and increased urinary frequency, owing to the non-selective properties of this agent and the potential to cross the blood brain barrier; however, more-selective blockers of the α1-receptor such as tamsulosin or alfuzosin are better suited for the management of bladder neck dysfunction that can lead to detrusor hypertrophy and instability. Non-selective α-blockers can cause postural hypotension. Therefore, these agents must be used carefully, and a gradual titration of the dose is required. In patients with a family history of fainting easily or postural hypotension, dose titration is essential even with the use of more-selective α- blockers. For the most part, children tolerate α-blockers well.<a class="citation" href="#vanderbrink2009a"><span style="vertical-align: super">75</span></a></p>

<h4 id="beta-3-agonists">
<a class="anchor" href="#beta-3-agonists" aria-hidden="true"><span class="octicon octicon-link"></span></a>Beta-3 Agonists</h4>

<p>Agonists of the β<sub>3</sub> adrenoceptor, such as mirabegron can increase bladder capacity without increasing voiding pressure or post-void residual volume.<a class="citation" href="#andersson2009a"><span style="vertical-align: super">76</span></a> Treatment with these agents leads to smooth muscle relaxation and the generally accepted mechanism of relaxation is via downstream activation of adenyl cyclase with the subsequent production of cyclic adenosine monophosphate (<abbr title="cyclic adenosine monophosphate">cAMP</abbr>) followed by inhibition of the Rho-kinase pathway<strong>.</strong><a class="citation" href="#uchida2005a"><span style="vertical-align: super">77,78</span></a> However, evidence also indicates that elevated <abbr title="cyclic adenosine monophosphate">cAMP</abbr> also activates protein kinase A, which then activates large-conductance calcium-dependent K<sup>+</sup> (<abbr title="large-conductance calcium-dependent potassium">BK</abbr>) channels. Activation of these <abbr title="large-conductance calcium-dependent potassium">BK</abbr> channels leads to hyperpolarization of bladder smooth muscle and increased detrusor stability.<a class="citation" href="#kobayashi2000a"><span style="vertical-align: super">79</span></a> Mirabegron is approved for treatment of <abbr title="overactive bladder">OAB</abbr> in adults and children in the <abbr>US</abbr> and Europe.</p>

<h4 id="other-medications">
<a class="anchor" href="#other-medications" aria-hidden="true"><span class="octicon octicon-link"></span></a>Other Medications</h4>

<p>Imipramine is a tricyclic antidepressant that affects both muscarinic receptors and α-adrenoceptors with a possible central effect on voiding reflexes.<a class="citation" href="#hunsballe2001a"><span style="vertical-align: super">80</span></a> When imipramine was introduced to treat depression it was found to have marked effects on patients’ urinary incontinence. We have found imipramine to be an effective agent in controlling urge incontinence in some children who were previously found to be refractory to antimuscarinic therapy.<a class="citation" href="#franco2018b"><span style="vertical-align: super">81</span></a> The effects of imipramine on urinary incontinence might be the result of an effect in the frontal areas of the brain which are involved in executive functioning including control of urinary urgency. Alternatively, the urological effects of imipramine might reflect an effect on dopamine levels in the striatum thereby affecting ɣ-aminobutyric acid (<abbr title="gamma-aminobutyric acid">GABA</abbr>) levels in the <abbr title="periaqueductal gray">PAG</abbr>. Increased <abbr title="gamma-aminobutyric acid">GABA</abbr> levels in the <abbr title="periaqueductal gray">PAG</abbr> impart suppression of the voiding reflex.<a class="citation" href="#groat2015a"><span style="vertical-align: super">82,83</span></a></p>

<p>Imipramine has also been found to be useful in treating our patients with giggle incontinence. Imipramine can cause postural hypotension and can also be dangerous in patients with cardiac conduction abnormalities and must be used with caution.</p>

<h4 id="ssris-and-snris">
<a class="anchor" href="#ssris-and-snris" aria-hidden="true"><span class="octicon octicon-link"></span></a><abbr title="Selective serotonin reuptake inhibitors">SSRIs</abbr> and SNRIs</h4>

<p>Selective serotonin reuptake inhibitors (<abbr title="Selective serotonin reuptake inhibitors">SSRIs</abbr>) have been shown to function at Onuf’s nucleus by modulating the voiding and storage reflexes which are dependent on glutamate. In the presence of glutamate, <abbr title="Selective serotonin reuptake inhibitors">SSRIs</abbr> augment the effects of incoming signals for bladder storage and also augment output to the external urethral sphincter thereby maintaining contraction of this sphincter. In the absence of glutamate, <abbr title="Selective serotonin reuptake inhibitors">SSRIs</abbr> have no effect upon signaling and normal parasympathetic activation resulting in contraction of the bladder and relaxation of the sphincter.<a class="citation" href="#schuessler2006a"><span style="vertical-align: super">84</span></a> This effect of <abbr title="Selective serotonin reuptake inhibitors">SSRIs</abbr> on the storage side of the reflex arc might explain how some patients’ bladder overactivity improves following treatment with <abbr title="Selective serotonin reuptake inhibitors">SSRIs</abbr>. These agents might also be acting in brain regions that are associated with processing of urgency signals, such as the <abbr title="anterior cingulate gyrus">ACG</abbr> and <abbr title="prefrontal cortex">PFC</abbr>.</p>

<h3 id="electrical-stimulation">
<a class="anchor" href="#electrical-stimulation" aria-hidden="true"><span class="octicon octicon-link"></span></a>Electrical Stimulation</h3>

<h4 id="sacral-neurostimulation">
<a class="anchor" href="#sacral-neurostimulation" aria-hidden="true"><span class="octicon octicon-link"></span></a>Sacral Neurostimulation</h4>

<p>Sacral neurostimulation (also known as sacral neuromodulation) involves the placement of a wire lead into the S<sub>3</sub> foramina and along the sacral nerve with subcutaneous implantation of a stimulator to provide continuous low-intensity stimulation of the nerve. Spinal cord stimulation is frequently used in adult patients and interest in the use of this approach in children is increasing. In a series of 20 prospectively monitored patients with dysfunctional elimination syndrome, described by Roth <em>et al</em> cessation of symptoms or a &gt;50% improvement in symptoms occurred in 88% of children of whom 63% had nocturnal enuresis, 89% had increased daytime urinary frequency, and 59% had constipation. This group now has experience with sacral neurostimulation in 187 patients, with consistent outcomes.<a class="citation" href="#roth2008a"><span style="vertical-align: super">85,86</span></a></p>

<h4 id="parasacral-stimulation-with-transcutaneous-electrical-nerve-stimulation">
<a class="anchor" href="#parasacral-stimulation-with-transcutaneous-electrical-nerve-stimulation" aria-hidden="true"><span class="octicon octicon-link"></span></a>Parasacral Stimulation with Transcutaneous Electrical Nerve Stimulation</h4>

<p>Parasacral stimulation involves the use of a <abbr title="transcutaneous electrical nerve stimulation">TENS</abbr> device and parasacral conducting pads, which are placed parasacrally in the S2–3 region while the electrodes are connected on the surface to a current generator. Studies have used stimulation at various frequencies, ranging from 10–80 Hz and frequencies of treatment ranging from weekly to daily. Durations of stimulation have also varied from 20 minutes up to 1 hour daily. Walsh <em>et al</em> first described the use of <abbr title="transcutaneous electrical nerve stimulation">TENS</abbr> in adults in 1999 followed by Hoebeke <em>et al</em> in 2001 who described usage in children.<a class="citation" href="#balken2004a"><span style="vertical-align: super">87,88</span></a> In subsequent studies, complete resolution of symptoms has ranged from 47–61.9% of children treated with this modality.<a class="citation" href="#bower2001a"><span style="vertical-align: super">89,90,91</span></a> This modality has also been found useful in stimulating bowel motility using cross inferential current.<a class="citation" href="#chase2005a"><span style="vertical-align: super">92</span></a></p>

<h4 id="tibial-peripheral-nerve-stimulation">
<a class="anchor" href="#tibial-peripheral-nerve-stimulation" aria-hidden="true"><span class="octicon octicon-link"></span></a>Tibial Peripheral Nerve Stimulation</h4>

<p>Percutaneous electrical tibial nerve stimulation (<abbr title="posterior tibial nerve stimulation">PTNS</abbr>) is based on the traditional Chinese practice of using acupuncture points over the common peroneal posterior tibial nerves to inhibit bladder activity.<a class="citation" href="#balken2004a"><span style="vertical-align: super">87,88</span></a> One technique involves using a 34-gauge stainless steel needle, which is inserted approximately 5 cm cephalad to the medial malleolus, just posterior to the margin of the tibia. A stick-on electrode is placed on the medial surface of the calcaneus. This approach has been evaluated in clinical trials with variable results. Hoebeke <em>et al</em> reported that 17 out of 28 children whose <abbr title="overactive bladder">OAB</abbr> symptoms were refractory to medical treatment had either resolution or improvement of their symptoms in response to weekly 30-minute <abbr title="posterior tibial nerve stimulation">PTNS</abbr> sessions.<a class="citation" href="#hoebeke2002a"><span style="vertical-align: super">91</span></a> DeGennaro <em>et al</em> reported after long-term follow-up monitoring that 12 of 14 children with <abbr title="overactive bladder">OAB</abbr> and 14 of 14 with dysfunctional voiding were asymptomatic after two years.<a class="citation" href="#capitanucci2009a"><span style="vertical-align: super">88</span></a> The authors did note that ‘chronic’ persistent long term <abbr title="posterior tibial nerve stimulation">PTNS</abbr> use was required in 50% and 29% of children with <abbr title="overactive bladder">OAB</abbr> and dysfunctional voiding respectively to maintain these results. In a study that compared the efficacy of <abbr title="transcutaneous electrical nerve stimulation">TENS</abbr> delivered to the parasacral region with that of <abbr title="posterior tibial nerve stimulation">PTNS</abbr> in children with <abbr title="overactive bladder">OAB</abbr>, significantly better outcomes were observed with use of <abbr title="transcutaneous electrical nerve stimulation">TENS</abbr> compared with <abbr title="posterior tibial nerve stimulation">PTNS</abbr> (complete resolution observed in 70% versus 9% of patients, respectively; <em>P</em> = 0.02).<a class="citation" href="#barroso2013a"><span style="vertical-align: super">93</span></a> <a href="#figure-5" class="figure-link">Figure 5</a> shows such a device.</p>

<p><img src="https://beta.pediatricurologybook.com/assets/figures/figure-20-5.jpeg" alt="Figure 5" class="float-start img-fluid"><br>
<strong id="figure-5" class="figure-number">Figure 5</strong> <abbr title="posterior tibial nerve stimulation">PTNS</abbr> stimulation in a child.</p>

<p>Another form of tibial nerve stimulation is to apply patches over the nerve and stimulate the nerve like parasacral <abbr title="transcutaneous electrical nerve stimulation">TENS</abbr>. In a study comparing transcutaneous posterior tibial stimulation and sham stimulation in 40 children QoL scores, overall and day-time <abbr title="Dysfunctional Voiding and Incontinence Symptom Scoree">DVISS</abbr> scores were significantly decreased in both sham and test groups (p &lt; 0.05). Additionally, the frequency of incontinence and urgency episodes were also significantly reduced (p &lt; 0.05) in the <abbr title="posterior tibial nerve stimulation">PTNS</abbr> treatment group. This effect in the test group was still valid 2 years after intervention.<a class="citation" href="#jafarov2021a"><span style="vertical-align: super">94</span></a></p>

<h3 id="surgical-options">
<a class="anchor" href="#surgical-options" aria-hidden="true"><span class="octicon octicon-link"></span></a>Surgical Options</h3>

<h4 id="botulinum-toxin-a">
<a class="anchor" href="#botulinum-toxin-a" aria-hidden="true"><span class="octicon octicon-link"></span></a>Botulinum Toxin A</h4>

<p>Intravesical injections of botulinum toxin A (<abbr title="Botulinum Toxin A">BoNT-A</abbr>) into the detrusor have been approved for use in adults with <abbr title="overactive bladder">OAB</abbr>. A recent study published by Austin <em>et al</em> in neurogenic patients has proven safety of <abbr title="Botulinum Toxin A">BoNT-A</abbr> in children and resulted in <abbr title="Food and Drug Administration">FDA</abbr> approval in children with <abbr title="neurogenic detrusor overactivity">NDO</abbr>.<a class="citation" href="#austin2021a"><span style="vertical-align: super">95</span></a> In adults, <abbr title="Botulinum Toxin A">BoNT-A</abbr> injections have proven a useful treatment of patients with refractory <abbr title="overactive bladder">OAB</abbr> and offer an alternative to patients that cannot tolerate anticholinergic therapy. Limited published studies are available on the use of <abbr title="Botulinum Toxin A">BoNT-A</abbr> in children primarily consisting of nonrandomized selected clinical cohorts of neurologically healthy children with treatment refractory <abbr title="overactive bladder">OAB</abbr> and urge incontinence.<a class="citation" href="#hoebeke2006a"><span style="vertical-align: super">96,97,98</span></a> The dose of <abbr title="Botulinum Toxin A">BoNT-A</abbr> is variable in these studies and ranges from 50–200 units.<a class="citation" href="#hoebeke2006a"><span style="vertical-align: super">96,97,98</span></a> The follow-up data from these three studies, total of 55 patients, reveal that a full response defined by complete continence was achieved in 38–70% of these children after a single, or repeat injections. Few clinically significant adverse events were reported; one patient had a <abbr title="urinary tract infection">UTI</abbr> and one patient had temporary urinary retention.<a class="citation" href="#hoebeke2006a"><span style="vertical-align: super">96,97</span></a></p>

<h3 id="biofeedback">
<a class="anchor" href="#biofeedback" aria-hidden="true"><span class="octicon octicon-link"></span></a>Biofeedback</h3>

<p>Biofeedback is the process of gaining greater awareness of pelvic floor muscle/sphincter action using external instruments that provide information about the action of these muscles with the goal of increasing awareness and voluntary control by the child.</p>

<p>Within specific urotherapy, the focus is often on pelvic floor rehabilitation using biofeedback training. The theoretical benefit of biofeedback is that children are able to directly visualize the activity of their pelvic floor muscles by <abbr title="electromyography">EMG</abbr> or uroflow curve.<a class="citation" href="#chase2010a"><span style="vertical-align: super">99</span></a> This facilitates defecation and helps the child to get awareness of pelvic floor muscle (contraction vs relaxation). In dysfunctional voiding due to external sphincter dyssynergia the aim is to achieve relaxed unobstructed voiding and complete bladder emptying. Feedback can be given immediately about performance as with <abbr title="electromyography">EMG</abbr> or ultrasound or knowledge of results as with uroflowmetry and post void residual measurement.<a class="citation" href="#clothier2018a"><span style="vertical-align: super">100</span></a></p>

<p>The feedback from <abbr title="electromyography">EMG</abbr> can be used to teach the child to contract and relax the pelvic floor muscles at will.<a class="citation" href="#chase2010a"><span style="vertical-align: super">99</span></a> Using real time flowmetry helps the child to observe the flow curve during voiding. Children can be taught to urinate with a relaxed pelvic floor muscle and normal urine volume by achieving a continuous, bell-shaped flow curve. Ultrasound can be used to check if the bladder is empty after urination and report this to the child.</p>

<p>The impact of biofeedback in dysfunctional voiders who have reflux is significant in that we saw 60% spontaneous resolution of reflux in children 6 years and older treated with biofeedback.<a class="citation" href="#palmer2002a"><span style="vertical-align: super">101</span></a> Some have claimed that biofeedback is effective for urgency as well its mechanism may be via reduction of the outlet resistance during voiding which leads to detrusor hypertrophy thereby leading to detrusor instability. On the other hand there are studies in adults that indicate it may be effective in <abbr title="overactive bladder">OAB</abbr> patients due to the continual one to one therapy received by the patient and improvement in the mental well-being of the patient.<a class="citation" href="#resnick2013a"><span style="vertical-align: super">102</span></a></p>

<p>Biofeedback therapy is limited by the ability of the child to cooperate with the healthcare provider running the session. Children younger than five years of age typically are incapable of doing biofeedback on a regular basis. Children with significant learning disabilities, behavior problems and other neurologic problems are not ideal candidates for biofeedback. Additional studies reveal that biofeedback therapy is useful in the elimination of reflux in children that exhibit evidence of external sphincter dyssynergia.<a class="citation" href="#kibar2007a"><span style="vertical-align: super">103,104</span></a></p>

<p>It is a misunderstanding that biofeedback alone is sufficient to achieve continence. In practice, professionals inadvertently combine biofeedback with education and instructions. By doing this, they also provide behavioral modification whilst thinking that they only provide biofeedback training. In urotherapy, biofeedback is merely one of the elements of treatment, type of biofeedback is not a decisive factor in treatment outcome.<a class="citation" href="#nieuwhof-leppink2021a"><span style="vertical-align: super">51</span></a></p>

<h2 id="disorders">
<a class="anchor" href="#disorders" aria-hidden="true"><span class="octicon octicon-link"></span></a>Disorders</h2>

<h3 id="overactive-bladder">
<a class="anchor" href="#overactive-bladder" aria-hidden="true"><span class="octicon octicon-link"></span></a>Overactive Bladder</h3>

<h4 id="evaluation-and-diagnosis">
<a class="anchor" href="#evaluation-and-diagnosis" aria-hidden="true"><span class="octicon octicon-link"></span></a>Evaluation and Diagnosis</h4>

<p>The hallmark of <abbr title="overactive bladder">OAB</abbr> is urgency and by definition, children with this symptom can be said to have an <abbr title="overactive bladder">OAB</abbr>. Incontinence and increased voiding frequency are often present. Urge incontinence simply means incontinence in the presence of urgency and is applicable to many children with <abbr title="overactive bladder">OAB</abbr>. There is mounting evidence that <abbr title="overactive bladder">OAB</abbr> is a sensory problem; whether it is located in the central nervous system (<abbr title="central nervous system">CNS</abbr>) or at the bladder level is a matter for debate. Children with incontinence not associated with a sudden urge to void or who are late to recognize the urge are more likely to have a neurologic problem or are more likely to have an issue with frontal lobe processing such as <abbr title="attention deficit hyperactivity disorder">ADHD</abbr>.</p>

<h4 id="treatment-options-and-pitfalls">
<a class="anchor" href="#treatment-options-and-pitfalls" aria-hidden="true"><span class="octicon octicon-link"></span></a>Treatment Options and Pitfalls</h4>

<ol>
  <li>Urotherapy, bowel program
    <ol>
      <li>Avoid diarrhea or fecal accidents with poorly controlled or over aggressive use of osmotic agents and cathartics</li>
      <li>Avoid excessive gas from overloading with fiber; gas is just as detrimental as constipation and results in distention of the gut</li>
      <li>Fiber supplementation without water leads to worsening of the constipation</li>
    </ol>
  </li>
  <li>Anticholinergics or Terazosin or Doxazosin
    <ol>
      <li>Dry mouth or memory problems can be due to anticholinergic medications. Watch for constipation becoming worse with anticholinergics</li>
      <li>Dizziness and fatigue due to alpha blockers can be prevented by ensuring patients hydrate and increase salt intake.</li>
    </ol>
  </li>
  <li>Evaluate for neuropsychiatric problems and treating accordingly
    <ol>
      <li>
<abbr title="Selective serotonin reuptake inhibitors">SSRIs</abbr> can be associated with irritability and suicidal thoughts</li>
      <li>Sympathomimetics for <abbr title="attention deficit hyperactivity disorder">ADHD</abbr> can lead to tightening of the bladder neck and potential negative effects on flow rates and even dysuria. Weight loss and constipation are associated with sympathomimetics.</li>
    </ol>
  </li>
  <li>Consider <abbr title="posterior tibial nerve stimulation">PTNS</abbr> or <abbr title="transcutaneous electrical nerve stimulation">TENS</abbr>
    <ol>
      <li>Some children have a fear of needles and <abbr title="posterior tibial nerve stimulation">PTNS</abbr> is not feasible</li>
      <li>Some children can overreact to the sensation and not tolerate therapy</li>
    </ol>
  </li>
  <li>If resistant, can consider imipramine if failed treatments
    <ol>
      <li>Can be associated with irritability and suicidal thoughts</li>
      <li>Can unmask bipolar disorder especially if a family history exists</li>
      <li>Do not give the medication to patients with a familial history of conduction defects or sudden cardiac death</li>
      <li>Medication must be under control of an adult at all times</li>
    </ol>
  </li>
  <li>If no evidence of elevated residuals can consider Botulinum Toxin A injections to detrusor
    <ol>
      <li>Patients with flow indexes below 0.3 or elevated residuals &gt;150 cc should not receive Botulinum Toxin A injections due to the possibility of retention/<abbr title="clean, intermittent catheterization">CIC</abbr>
</li>
    </ol>
  </li>
  <li>If all else fails can consider sacral neuromodulation
    <ol>
      <li>Complications with lead displacement</li>
    </ol>
  </li>
</ol>

<h3 id="dysfunctional-voiding">
<a class="anchor" href="#dysfunctional-voiding" aria-hidden="true"><span class="octicon octicon-link"></span></a>Dysfunctional Voiding</h3>

<h4 id="evaluation-and-diagnosis-1">
<a class="anchor" href="#evaluation-and-diagnosis-1" aria-hidden="true"><span class="octicon octicon-link"></span></a>Evaluation and Diagnosis</h4>

<p>The child with dysfunctional voiding habitually contracts the urethral sphincter during voiding. Uroflowmetry with <abbr title="electromyography">EMG</abbr> is necessary to confirm the presence of sphincter contraction during voiding. Note that the term describes malfunction during the voiding phase only. The term dysfunctional voiding is independent of the storage phase. It is entirely possible for a child to experience dysfunctional voiding and storage symptoms such as incontinence, urgency or frequency thereby presenting two issues that require correction.</p>

<h4 id="treatment-options-and-their-pitfalls">
<a class="anchor" href="#treatment-options-and-their-pitfalls" aria-hidden="true"><span class="octicon octicon-link"></span></a>Treatment Options and Their Pitfalls</h4>

<ol>
  <li>Urotherapy, bowel program
    <ol>
      <li>Avoid diarrhea or fecal accidents with poorly controlled or over aggressive use of osmotic agents and cathartics</li>
      <li>Avoid excessive gas from overloading with fiber; gas is just as detrimental as constipation and results in distention of the gut</li>
      <li>Fiber supplementation without water leads to worsening of the constipation</li>
    </ol>
  </li>
  <li>Repeat uroflowmetry and confirm if the problem persists</li>
  <li>If etiology is external sphincter dyssynergia (<abbr title="external sphincter dyssynergia">ESS</abbr>)
    <ol>
      <li>Biofeedback</li>
      <li>Timed voiding to prevent infrequent voiding</li>
      <li>Manage detrusor overactivity if present. If overactivity is not adequately managed patients will continue to have urgency which will undo the biofeedback performed.</li>
    </ol>
  </li>
  <li>If etiology is internal sphincter dyssynergia (<abbr title="internal sphincter dyssynergia">ISS</abbr>)
    <ol>
      <li>Alpha blockers
        <ol>
          <li>Dizziness and fatigue due to alpha blockers can be prevented by ensuring patients hydrate well and increase salt intake.</li>
        </ol>
      </li>
      <li>If evidence of <abbr title="external sphincter dyssynergia">ESS</abbr>, treat with biofeedback</li>
      <li>Continue bowel regimen</li>
      <li>Manage detrusor overactivity if present
        <ol>
          <li>Anticholinergics or Terazosin or Doxazosin
            <ol>
              <li>problems with dry mouth or memory problems can be due to anticholinergic medications. Watch for constipation becoming worse with anticholinergics.</li>
              <li>Dizziness and fatigue due to alpha blockers can be prevented by ensuring patients hydrate well and increase salt intake.</li>
            </ol>
          </li>
        </ol>
      </li>
    </ol>
  </li>
</ol>

<h3 id="bulbar-urethritisurethrorrhagia">
<a class="anchor" href="#bulbar-urethritisurethrorrhagia" aria-hidden="true"><span class="octicon octicon-link"></span></a>Bulbar Urethritis/Urethrorrhagia</h3>

<h4 id="evaluation-and-diagnosis-2">
<a class="anchor" href="#evaluation-and-diagnosis-2" aria-hidden="true"><span class="octicon octicon-link"></span></a>Evaluation and Diagnosis</h4>

<p>Pain associated with voiding is commonly seen in patients with some form of dyssynergic voiding. In patients who have bulbar urethritis (dysuria/urethrorrhagia syndrome), the pain at the tip or along the shaft of the penis is most likely due to dyssynergic voiding. Correction of the voiding pattern eliminated the symptoms.<a class="citation" href="#herz2005a"><span style="vertical-align: super">33</span></a> In girls, vaginal or urethral pain can also indicate an abnormal pattern.</p>

<h3 id="underactive-bladder">
<a class="anchor" href="#underactive-bladder" aria-hidden="true"><span class="octicon octicon-link"></span></a>Underactive Bladder</h3>

<h4 id="evaluation-and-diagnosis-3">
<a class="anchor" href="#evaluation-and-diagnosis-3" aria-hidden="true"><span class="octicon octicon-link"></span></a>Evaluation and Diagnosis</h4>

<p>The old entity “lazy bladder” has replaced by the neutral term underactive bladder and is reserved for children with low voiding frequency and a need to increase intra-abdominal pressure to initiate, maintain or complete voiding (i.e., strainin). Children often produce an interrupted pattern on uroflowmetry. Formal diagnosis is confirmed with the use of urodynamics that demonstrate low voiding pressures. Unfortunately, there are no formal definitions for normal voiding pressures in children so we tend to use the pressures for adults.</p>

<h4 id="treatment-options-and-pitfalls-1">
<a class="anchor" href="#treatment-options-and-pitfalls-1" aria-hidden="true"><span class="octicon octicon-link"></span></a>Treatment Options and Pitfalls</h4>

<ol>
  <li>Evaluations will include a uroflowmetry with pelvic floor <abbr title="electromyography">EMG</abbr> and if possible a second abdominal muscle <abbr title="electromyography">EMG</abbr>.</li>
  <li>If abdominal straining is evident with a weak inefficient flow rate (flow index &lt;0.7) and elevated postvoid residual, consider the diagnosis of <abbr title="underactive bladder">UAB</abbr>.</li>
  <li>Confirm with urodynamics</li>
  <li>Consider alpha blockers to help open bladder neck and improve emptying</li>
  <li>Up to 50% of patients also have <abbr title="overactive bladder">OAB</abbr> and need treatment of <abbr title="overactive bladder">OAB</abbr> to prevent incontinence or recurrent <abbr title="urinary tract infections">UTIs</abbr>
</li>
  <li>
<abbr title="internal sphincter dyssynergia">ISS</abbr> is commonly seen in <abbr title="underactive bladder">UAB</abbr> patients and treatment with alpha blockers is necessary in these patients.</li>
  <li>Consider <abbr title="clean, intermittent catheterization">CIC</abbr> if patients have high <abbr title="post-void residual">PVR</abbr> and or have recurrent <abbr title="urinary tract infections">UTIs</abbr>; some have utilized sacral neuromodulation but with limited success</li>
</ol>

<h3 id="pollakiuria">
<a class="anchor" href="#pollakiuria" aria-hidden="true"><span class="octicon octicon-link"></span></a>Pollakiuria</h3>

<h4 id="evaluation-and-diagnosis-4">
<a class="anchor" href="#evaluation-and-diagnosis-4" aria-hidden="true"><span class="octicon octicon-link"></span></a>Evaluation and Diagnosis</h4>

<p>This term applies to children who void often and with small volumes during the daytime only. Daytime voiding frequency is at least once hourly and average voided volumes are less than 50% of estimated bladder capacity (<abbr title="estimated bladder capacity">EBC</abbr>), usually much smaller. Incontinence is not a usual or necessary ingredient in the condition and nocturnal bladder behavior is normal for the age of the child. The term is applicable from the age of daytime bladder control or 3 years.</p>

<h4 id="treatment-options-and-pitfalls-2">
<a class="anchor" href="#treatment-options-and-pitfalls-2" aria-hidden="true"><span class="octicon octicon-link"></span></a>Treatment Options and Pitfalls</h4>

<ol>
  <li>Evaluate the environment, commonly seen when a recent life event has occurred or there is an upcoming event such as the start of school, camp or holiday</li>
  <li>Make sure there is no new constipation or change in diet</li>
  <li>Initiate urotherapy, bowel program
    <ul>
      <li>Avoid diarrhea or fecal accidents with poorly controlled or over aggressive use of osmotic agents and cathartics</li>
      <li>Avoid excessive gas from overloading with fiber; gas is just as detrimental as constipation and results in distention of the gut</li>
      <li>Fiber supplementation without water leads to worsening of the constipation</li>
    </ul>
  </li>
  <li>Consider Anticholinergics or Terazosin or Doxazosin
    <ul>
      <li>Dry mouth or memory problems can be due to anticholinergic medications. Watch for constipation becoming worse with anticholinergics</li>
      <li>Dizziness and fatigue due to alpha blockers can be prevented by ensuring patients hydrate well and increase salt intake.</li>
    </ul>
  </li>
  <li>Evaluate for neuropsychiatric problems if present consider treating accordingly
    <ul>
      <li>
<abbr title="Selective serotonin reuptake inhibitors">SSRIs</abbr> can be associated with irritability and suicidal thoughts</li>
      <li>Sympathomimetics for <abbr title="attention deficit hyperactivity disorder">ADHD</abbr> can lead to tightening of bladder neck and potential negative effects on flow rates and even dysuria. Weight loss and constipation are associated with sympathomimetics.</li>
    </ul>
  </li>
  <li>Can resolve spontaneously</li>
</ol>

<h3 id="giggle-incontinence">
<a class="anchor" href="#giggle-incontinence" aria-hidden="true"><span class="octicon octicon-link"></span></a>Giggle Incontinence</h3>

<h4 id="evaluation-and-diagnosis-5">
<a class="anchor" href="#evaluation-and-diagnosis-5" aria-hidden="true"><span class="octicon octicon-link"></span></a>Evaluation and Diagnosis</h4>

<p>Giggle incontinence is associated with complete voiding which occurs specifically during or immediately after laughing. Bladder function is normal when the child is not laughing. Giggle incontinence is clearly different than stress incontinence where voiding can be prevented or stopped volitionally.</p>

<h4 id="treatment-options-and-pitfalls-3">
<a class="anchor" href="#treatment-options-and-pitfalls-3" aria-hidden="true"><span class="octicon octicon-link"></span></a>Treatment Options and Pitfalls</h4>

<ol>
  <li>Confirm the diagnosis with a good history</li>
  <li>Commonly seen in children with underlying neuropsychiatric disorders</li>
  <li>Urotherapy and bowel regimen to make sure that this is not simple <abbr title="overactive bladder">OAB</abbr>
</li>
  <li>If no response, then initiate therapy
    <ol>
      <li>Imipramine: Initiate dosing at 10 mg and increase to max of 75 mg</li>
      <li>Atomoxetin: Initiate dosing at 10 mg and increase accordingly</li>
      <li>Sympathomimetics: Dosing depends on medication chosen, should be long-acting version otherwise the patient is at risk of accidents when the medication wears off</li>
      <li>
<abbr title="Selective serotonin reuptake inhibitors">SSRIs</abbr>: Dosing is dependent on medication, chose the lowest dose and gradually escalate.</li>
    </ol>
  </li>
  <li>All the above carry the same problems
    <ol>
      <li>can be associated with irritability and suicidal thoughts</li>
      <li>can unmask bipolar disorder if a family history exists</li>
      <li>do not give the medication to patients with a familial history of conduction defects or sudden cardiac death</li>
      <li>Medication must be under control of an adult at all times</li>
    </ol>
  </li>
</ol>

<h3 id="vaginal-voiding">
<a class="anchor" href="#vaginal-voiding" aria-hidden="true"><span class="octicon octicon-link"></span></a>Vaginal Voiding</h3>

<h4 id="evaluation-and-diagnosis-6">
<a class="anchor" href="#evaluation-and-diagnosis-6" aria-hidden="true"><span class="octicon octicon-link"></span></a>Evaluation and Diagnosis</h4>

<p>Toilet trained prepubertal girls who wet their underwear within 10 minutes of voiding likely to be experiencing vaginal reflux if no underlying mechanism other than vaginal entrapment of urine is obvious. Vaginal voiding is not associated with other <abbr title="lower urinary tract">LUT</abbr> symptoms. It is essential to differentiate vaginal voiding from post void dribbling since the treatment is quite different.</p>

<h4 id="treatment-options-and-pitfalls-4">
<a class="anchor" href="#treatment-options-and-pitfalls-4" aria-hidden="true"><span class="octicon octicon-link"></span></a>Treatment Options and Pitfalls</h4>

<ol>
  <li>Confirm the diagnosis and differentiate from post void dribbling, stress and urge incontinence</li>
  <li>Commonly seen in young girls who do not pull clothes below the knee</li>
  <li>Commonly seen in girls who have prominent labial fat</li>
  <li>Commonly seen in girls who are obese</li>
  <li>Recommend patients sit on toilet with legs spread and thighs apart or sit facing the wall behind the toilet which forces the legs to be spread</li>
  <li>Frequently is associated with vaginal discharge and vaginitis</li>
  <li>Can be associated with lichen sclerosis of the labia</li>
</ol>

<h3 id="stress-incontinence">
<a class="anchor" href="#stress-incontinence" aria-hidden="true"><span class="octicon octicon-link"></span></a>Stress Incontinence</h3>

<h4 id="evaluation-and-diagnosis-7">
<a class="anchor" href="#evaluation-and-diagnosis-7" aria-hidden="true"><span class="octicon octicon-link"></span></a>Evaluation and Diagnosis</h4>

<p>Stress incontinence is the leakage of small amounts of urine at exertion or with increased intraabdominal pressure, typically associated with valsalva. It is rare in neurologically normal children. There is an increased association with hyperflexible girls involved in gymnastics and dance.<a class="citation" href="#bauer2018a"><span style="vertical-align: super">105</span></a></p>

<h4 id="treatment-options-and-pitfalls-5">
<a class="anchor" href="#treatment-options-and-pitfalls-5" aria-hidden="true"><span class="octicon octicon-link"></span></a>Treatment Options and Pitfalls</h4>

<ol>
  <li>Confirm diagnosis and differentiate from post void dribbling, stress and urge incontinence</li>
  <li>Surgical correction with open or laparoscopic burch<a class="citation" href="#dobrowolska-glazar2017a"><span style="vertical-align: super">106,107</span></a>
</li>
</ol>

<h2 class="key-points-head" id="key-points">
<a class="anchor" href="#key-points" aria-hidden="true"><span class="octicon octicon-link"></span></a>Key Points</h2>

<ul class="key-points-list">
  <li>
</ul>

<h2 id="conclusions">
<a class="anchor" href="#conclusions" aria-hidden="true"><span class="octicon octicon-link"></span></a>Conclusions</h2>

<p>asdf</p>

<h2 id="references">
<a class="anchor" href="#references" aria-hidden="true"><span class="octicon octicon-link"></span></a>References</h2>

<ol class="bibliography">
<li>
<span id="ruarte1987a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Ruarte AC, E Q</b></span>. <span style="font-variant: normal">Urodynamic Evaluation in Normal Children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">1987; <b>127</b> (4)</span>: <span style="text-decoration: none">831–831</span>. <span style="text-decoration: underline">DOI: 10.1016/s0022-5347(17)54062-8</span></span>.</span></span>   <a href="https://doi.org/10.1016/s0022-5347(17)54062-8" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="landgraf2004a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Landgraf JM, Abidari J, Cilento BG, Cooper CS, Schulman SL, Ortenberg J</b></span>. <span style="font-variant: normal">Coping, Commitment, and Attitude: Quantifying the Everyday Burden of Enuresis on Children and Their Families</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatrics</i></span> <span style="text-decoration: none">2004; <b>113</b> (2)</span>: <span style="text-decoration: none">334–344</span>. <span style="text-decoration: underline">DOI: 10.1542/peds.113.2.334</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/14754946/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1542/peds.113.2.334" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="fitzgerald2006a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Rovner ES</b></span>. <span style="font-variant: normal">Childhood Urinary Symptoms Predict Adult Overactive Bladder Symptoms</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Yearbook of Urology</i></span> <span style="text-decoration: none">2006; <b>2007</b></span>: <span style="text-decoration: none">65–66</span>. <span style="text-decoration: underline">DOI: 10.1016/s0084-4071(08)70046-0</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/16469599/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/s0084-4071(08)70046-0" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="minassian2006a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Minassian VA, Lovatsis D, Pascali D, Alarab M, Drutz HP</b></span>. <span style="font-variant: normal">The Effect of Childhood Dysfunctional Voiding on Urinary Incontinence in Adult Women</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Obstet Gynecol</i></span> <span style="text-decoration: none">2006; <b>107</b> (Supplement)</span>: <span style="text-decoration: none">47s</span>. <span style="text-decoration: underline">DOI: 10.1097/00006250-200604001-00112</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/16738148/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/00006250-200604001-00112" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="labrie2010a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Labrie J, Jong TPVM de, Nieuwhof-Leppink A, Deure J van der, Vijverberg MAW, Vaart CH van der</b></span>. <span style="font-variant: normal">The Relationship Between Children With Voiding Problems and Their Parents</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2010; <b>183</b> (5)</span>: <span style="text-decoration: none">1887–1891</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2010.01.004</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/20303097/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2010.01.004" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="wennberg2011a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Wennberg A-L, Altman D, Lundholm C, Klint Å, Iliadou A, Peeker R, <i>et al.</i></b></span>. <span style="font-variant: normal">Genetic Influences Are Important for Most But Not All Lower Urinary Tract Symptoms: A Population-Based Survey in a Cohort of Adult Swedish Twins</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Eur Urol</i></span> <span style="text-decoration: none">2011; <b>59</b> (6)</span>: <span style="text-decoration: none">1032–1038</span>. <span style="text-decoration: underline">DOI: 10.1016/j.eururo.2011.03.007</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/21420232/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.eururo.2011.03.007" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="cartwright2014a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Kaplan SA</b></span>. <span style="font-variant: normal">Re: Systematic Review and Meta-Analysis of Candidate Gene Association Studies of Lower Urinary Tract Symptoms in Men</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2014; <b>195</b> (6)</span>: <span style="text-decoration: none">1839–1840</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2016.03.051</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/24491308/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2016.03.051" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="botlero-a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Botlero R, Bell RJ, Urquhart DM, Davis SR</b></span>. <span style="font-variant: normal">Urinary incontinence is associated with lower psychological general well-being in community-dwelling women</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Menopause</i></span> <span style="text-decoration: none">2010; <b>17</b> (2)</span>: <span style="text-decoration: none">332–337</span>. <span style="text-decoration: underline">DOI: 10.1097/gme.0b013e3181ba571a</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/20216275/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/gme.0b013e3181ba571a" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="melville2009a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Melville JL, Fan M-Y, Rau H, Nygaard IE, Katon WJ</b></span>. <span style="font-variant: normal">Major depression and urinary incontinence in women: temporal associations in an epidemiologic sample</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Am J Obstet Gynecol</i></span> <span style="text-decoration: none">2009; <b>201</b> (5)</span>: <span style="text-decoration: none">490.e1–490.e7</span>. <span style="text-decoration: underline">DOI: 10.1016/j.ajog.2009.05.047</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/19716547/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.ajog.2009.05.047" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="henin2007a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Henin A, Biederman J, Mick E, Hirshfeld-Becker DR, Sachs GS, Wu Y, <i>et al.</i></b></span>. <span style="font-variant: normal">Childhood antecedent disorders to bipolar disorder in adults: A controlled study</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Affect Disord</i></span> <span style="text-decoration: none">2007; <b>99</b> (1-3)</span>: <span style="text-decoration: none">51–57</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jad.2006.09.001</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/17045657/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jad.2006.09.001" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="weissman2004a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Weissman MM, Gross R, Fyer A, Heiman GA, Gameroff MJ, Hodge SE, <i>et al.</i></b></span>. <span style="font-variant: normal">Interstitial Cystitis and Panic Disorder</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Arch Gen Psychiatry</i></span> <span style="text-decoration: none">2004; <b>61</b> (3)</span>: <span style="text-decoration: none">273</span>. <span style="text-decoration: underline">DOI: 10.1001/archpsyc.61.3.273</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/14993115/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1001/archpsyc.61.3.273" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="hyde2008a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Stockman JA</b></span>. <span style="font-variant: normal">Enuresis as a premorbid developmental marker of schizophrenia</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Yearbook of Pediatrics</i></span> <span style="text-decoration: none">2008; <b>2010</b></span>: <span style="text-decoration: none">396–398</span>. <span style="text-decoration: underline">DOI: 10.1016/s0084-3954(09)79524-7</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/18669483/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/s0084-3954(09)79524-7" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="fowler2010a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Fowler CJ, Griffiths DJ</b></span>. <span style="font-variant: normal">A decade of functional brain imaging applied to bladder control</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Neurourol Urodyn</i></span> <span style="text-decoration: none">2010; <b>29</b> (1)</span>: <span style="text-decoration: none">49–55</span>. <span style="text-decoration: underline">DOI: 10.1002/nau.20740</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/19412958/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1002/nau.20740" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="fowler2008a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Fowler CJ, Griffiths D, Groat WC de</b></span>. <span style="font-variant: normal">The neural control of micturition</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Nat Rev Neurosci</i></span> <span style="text-decoration: none">2008; <b>9</b> (6)</span>: <span style="text-decoration: none">453–466</span>. <span style="text-decoration: underline">DOI: 10.1038/nrn2401</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/18490916/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1038/nrn2401" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="hansen1997a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Hansen A, Hansen B, Dahm TL</b></span>. <span style="font-variant: normal">Urinary tract infection, day wetting and other voiding symptoms in seven-to eight-year-old Danish children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Acta Paediatr</i></span> <span style="text-decoration: none">1997; <b>86</b> (12)</span>: <span style="text-decoration: none">1345–1349</span>. <span style="text-decoration: underline">DOI: 10.1111/j.1651-2227.1997.tb14911.x</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/9475314/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1111/j.1651-2227.1997.tb14911.x" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="hellstrom1990a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Hellström A-L, Hanson E, Hansson S, Hjälmås K, Jodal U</b></span>. <span style="font-variant: normal">Micturition habits and incontinence in 7-year-old Swedish school entrants</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Eur J Pediatr</i></span> <span style="text-decoration: none">1990; <b>149</b> (6)</span>: <span style="text-decoration: none">434–437</span>. <span style="text-decoration: underline">DOI: 10.1007/bf02009667</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/2332015/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1007/bf02009667" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="lee2000a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Lee SD, Sohn DW, Lee JZ, Park NC, Chung MK</b></span>. <span style="font-variant: normal">An epidemiological study of enuresis in Korean children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>BJU Int</i></span> <span style="text-decoration: none">2000; <b>85</b> (7)</span>: <span style="text-decoration: none">869–873</span>. <span style="text-decoration: underline">DOI: 10.1046/j.1464-410x.2000.00617.x</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/10792168/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1046/j.1464-410x.2000.00617.x" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="safarinejad2007a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Safarinejad MR</b></span>. <span style="font-variant: normal">Prevalence of nocturnal enuresis, risk factors, associated familial factors and urinary pathology among school children in Iran</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2007; <b>3</b> (6)</span>: <span style="text-decoration: none">443–452</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2007.06.001</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/18947792/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2007.06.001" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="wekke1998a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Wekke J Spee-van der, Hirasing RA, Meulmeester JF, Radder JJ</b></span>. <span style="font-variant: normal">Childhood Nocturnal Enuresis in the Netherlands</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Urology</i></span> <span style="text-decoration: none">1998; <b>51</b> (6)</span>: <span style="text-decoration: none">1022–1026</span>. <span style="text-decoration: underline">DOI: 10.1016/s0090-4295(98)00106-x</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/9609644/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/s0090-4295(98)00106-x" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="swithinbank1998a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Swithinbank LV, Brookes ST, Shepherd AM, Abrams P</b></span>. <span style="font-variant: normal">The natural history of urinary symptoms during adolescence</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>BJU Int</i></span> <span style="text-decoration: none">1998; <b>81</b> (s3)</span>: <span style="text-decoration: none">90–93</span>. <span style="text-decoration: underline">DOI: 10.1046/j.1464-410x.1998.00016.x</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/9634028/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1046/j.1464-410x.1998.00016.x" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="yousef2003a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Deshpande AV, Craig JC, Smith GHH, Caldwell PHY</b></span>. <span style="font-variant: normal">Management of daytime urinary incontinence and lower urinary tract symptoms in children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Paediatr Child Health</i></span> <span style="text-decoration: none">2003; <b>48</b> (2)</span>: <span style="text-decoration: none">E44–e52</span>. <span style="text-decoration: underline">DOI: 10.1111/j.1440-1754.2011.02216.x</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/21060179/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1111/j.1440-1754.2011.02216.x" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="heron2008a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Heron J, Joinson C, Croudace T, Gontard A von</b></span>. <span style="font-variant: normal">Trajectories of Daytime Wetting and Soiling in a United Kingdom 4 to 9-Year-Old Population Birth Cohort Study</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2008; <b>179</b> (5)</span>: <span style="text-decoration: none">1970–1975</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2008.01.060</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/18355863/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2008.01.060" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="stone2010a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Stone JJ, Rozzelle CJ, Greenfield SP</b></span>. <span style="font-variant: normal">Intractable Voiding Dysfunction in Children With Normal Spinal Imaging: Predictors of Failed Conservative Management</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Urology</i></span> <span style="text-decoration: none">2010; <b>75</b> (1)</span>: <span style="text-decoration: none">161–165</span>. <span style="text-decoration: underline">DOI: 10.1016/j.urology.2009.06.100</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/19854476/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.urology.2009.06.100" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="tekgul-a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Tekgul S, R. N, Hoebeke P, Canning D, Bower W, Gontard A</b></span>. <span style="font-variant: normal">Incontinence</span>. <span style="text-decoration: underline"><span style="text-decoration: none">2009</span>: <span style="text-decoration: none">701–792</span></span>.</span></span> </li>
<li>
<span id="gontard-a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Gontard A, Nevéus T</b></span>. <span style="font-variant: normal">Management of disorders of bladder and bowel control in childhood</span>. <span style="text-decoration: underline"><span style="text-decoration: none">2006</span>. <span style="text-decoration: underline">DOI: 10.1136/adc.2006.110023</span></span>.</span></span>  <a href="https://doi.org/10.1136/adc.2006.110023" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="gontard2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Gontard A, Hussong J, Yang SS, Chase J, Franco I, Wright A</b></span>. <span style="font-variant: normal">Neurodevelopmental disorders and incontinence in children and adolescents: Attention-deficit/hyperactivity disorder, autism spectrum disorder, and intellectual disability–A consensus document of the International Children’s Continence Society</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Neurourol Urodyn</i></span> <span style="text-decoration: none">2021; <b>41</b> (1)</span>: <span style="text-decoration: none">102–114</span>. <span style="text-decoration: underline">DOI: 10.1002/nau.24798</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/34586694/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1002/nau.24798" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="joinson2006a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Joinson C, Heron J, Butler U, Gontard A von, Parents the Avon Longitudinal Study of, Team CS</b></span>. <span style="font-variant: normal">Psychological Differences Between Children With and Without Soiling Problems</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatrics</i></span> <span style="text-decoration: none">2006; <b>117</b> (5)</span>: <span style="text-decoration: none">1575–1584</span>. <span style="text-decoration: underline">DOI: 10.1542/peds.2005-1773</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/16651311/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1542/peds.2005-1773" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="joinson2008a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Joinson C, Heron J, Gontard A von, Butler U, Golding J, Emond A</b></span>. <span style="font-variant: normal">Early Childhood Risk Factors Associated with Daytime Wetting and Soiling in School-age Children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Psychol</i></span> <span style="text-decoration: none">2008; <b>33</b> (7)</span>: <span style="text-decoration: none">739–750</span>. <span style="text-decoration: underline">DOI: 10.1093/jpepsy/jsn008</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/18263629/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1093/jpepsy/jsn008" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="sureshkumar2009a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Sureshkumar P, Jones M, Cumming R, Craig J</b></span>. <span style="font-variant: normal">A Population Based Study of 2,856 School-Age Children With Urinary Incontinence</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2009; <b>181</b> (2)</span>: <span style="text-decoration: none">808–816</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2008.10.044</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/19110268/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2008.10.044" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="robson1997a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>ROBSON WMLANEM, JACKSON HAROLDP, BLACKHURST DAWN, LEUNG ALEXANDERk. C</b></span>. <span style="font-variant: normal">Enuresis in Children With Attention–Deficit Hyperactivity Disorder</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>South Med J</i></span> <span style="text-decoration: none">1997; <b>90</b> (5)</span>: <span style="text-decoration: none">503–505</span>. <span style="text-decoration: underline">DOI: 10.1097/00007611-199705000-00007</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/9160067/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/00007611-199705000-00007" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="moore1990a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>MOORE KATEH, SUTHERST JR</b></span>. <span style="font-variant: normal">Response to Treatment of Detrusor Instability in Relation to Psychoneurotic Status</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Br J Urol</i></span> <span style="text-decoration: none">1990; <b>66</b> (5)</span>: <span style="text-decoration: none">486–490</span>. <span style="text-decoration: underline">DOI: 10.1111/j.1464-410x.1990.tb14993.x</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/2249116/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1111/j.1464-410x.1990.tb14993.x" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="warne2381a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>WARNE STEPHANIEA, GODLEY MARGARETL, WILCOX DUNCANT</b></span>. <span style="font-variant: normal">Surgical Reconstruction Of Cloacal Malformation Can Alter Bladder Function: A Comparative Study With Anorectal Anomalies</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2381; <b>172</b> (6 Part 1)</span>: <span style="text-decoration: none">2377–2381</span>. <span style="text-decoration: underline">DOI: 10.1097/01.ju.0000145201.94571.67</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/15538272/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/01.ju.0000145201.94571.67" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="herz2005a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Coplen DE</b></span>. <span style="font-variant: normal">Dysfunctional Elimination Syndrome as an Etiology of Idiopathic Urethritis in Childhood</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Yearbook of Urology</i></span> <span style="text-decoration: none">2005; <b>2006</b></span>: <span style="text-decoration: none">257–258</span>. <span style="text-decoration: underline">DOI: 10.1016/s0084-4071(08)70411-1</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/15879866/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/s0084-4071(08)70411-1" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="pezzone2005a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Pezzone MA, Liang R, Fraser MO</b></span>. <span style="font-variant: normal">A Model of Neural Cross-Talk and Irritation in the Pelvis: Implications for the Overlap of Chronic Pelvic Pain Disorders</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Gastroenterology</i></span> <span style="text-decoration: none">2005; <b>128</b> (7)</span>: <span style="text-decoration: none">1953–1964</span>. <span style="text-decoration: underline">DOI: 10.1053/j.gastro.2005.03.008</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/15940629/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1053/j.gastro.2005.03.008" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="ustinova2006a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Ustinova EE, Fraser MO, Pezzone MA</b></span>. <span style="font-variant: normal">Colonic irritation in the rat sensitizes urinary bladder afferents to mechanical and chemical stimuli: an afferent origin of pelvic organ cross-sensitization</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Am J Physiol Renal Physiol</i></span> <span style="text-decoration: none">2006; <b>290</b> (6)</span>: <span style="text-decoration: none">F1478–f1487</span>. <span style="text-decoration: underline">DOI: 10.1152/ajprenal.00395.2005</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/16403832/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1152/ajprenal.00395.2005" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="franco2016a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Franco I, Grantham EC, Cubillos J, Franco J, Collett-Gardere T, Zelkovic P</b></span>. <span style="font-variant: normal">Can a simple question predict prolonged uroflow lag times in children?</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2016; <b>12</b> (3)</span>: <span style="text-decoration: none">157.e1–157.e8</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2015.12.009</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/26875871/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2015.12.009" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="lewis1997a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Lewis SJ, Heaton KW</b></span>. <span style="font-variant: normal">Stool Form Scale as a Useful Guide to Intestinal Transit Time</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Scand J Gastroenterol</i></span> <span style="text-decoration: none">1997; <b>32</b> (9)</span>: <span style="text-decoration: none">920–924</span>. <span style="text-decoration: underline">DOI: 10.3109/00365529709011203</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/9299672/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3109/00365529709011203" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="farhat2000a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>FARHAT WALID, B??GLI DARIUSJ, CAPOLICCHIO GIANPAOLO, O???REILLY SHEILA, MERGUERIAN PAULA, KHOURY ANTOINE, <i>et al.</i></b></span>. <span style="font-variant: normal">The Dysfunctional Voiding Scoring System: Quantitative Standardization Of Dysfunctional Voiding Symptoms In Children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2000; <b>164</b></span>: <span style="text-decoration: none">1011–1015</span>. <span style="text-decoration: underline">DOI: 10.1097/00005392-200009020-00023</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/10958730/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/00005392-200009020-00023" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="afshar2009a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Afshar K, Mirbagheri A, Scott H, MacNeily AE</b></span>. <span style="font-variant: normal">Development of a Symptom Score for Dysfunctional Elimination Syndrome</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2009; <b>182</b> (4s)</span>: <span style="text-decoration: none">1939–1944</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2009.03.009</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/19695637/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2009.03.009" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="hoecke2007a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Van Hoecke E, Baeyens D, Vanden Bossche H, Hoebeke P, Vande Walle J</b></span>. <span style="font-variant: normal">Early Detection of Psychological Problems in a Population of Children With Enuresis: Construction and Validation of the Short Screening Instrument for Psychological Problems in Enuresis</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2007; <b>178</b> (6)</span>: <span style="text-decoration: none">2611–2615</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2007.08.025</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/17945296/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2007.08.025" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="franco2016b"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Franco I, Shei-Dei Yang S, Chang S-J, Nussenblatt B, Franco JA</b></span>. <span style="font-variant: normal">A quantitative approach to the interpretation of uroflowmetry in children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Neurourol Urodyn</i></span> <span style="text-decoration: none">2016; <b>35</b> (7)</span>: <span style="text-decoration: none">836–846</span>. <span style="text-decoration: underline">DOI: 10.1002/nau.22813</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/26175192/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1002/nau.22813" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="franco2018a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Franco I, Franco JA, Nussenblatt B</b></span>. <span style="font-variant: normal">Can the idealized voider derived flow indexes be a measure of voiding efficiency and how accurate are they?</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>Neurourol Urodyn</i></span> <span style="text-decoration: none">2018; <b>37</b> (6)</span>: <span style="text-decoration: none">1913–1924</span>. <span style="text-decoration: underline">DOI: 10.1002/nau.23585</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/29664182/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1002/nau.23585" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="franco2016c"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Franco I, Franco J, Lee YS, Choi EK, Han SW</b></span>. <span style="font-variant: normal">Can a quantitative means be used to predict flow patterns: Agreement between visual inspection vs. flow index derived flow patterns</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2016; <b>12</b> (4)</span>: <span style="text-decoration: none">218.e1–218.e8</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2016.05.026</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/27427298/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2016.05.026" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="combs2005a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>COMBS ANDREWJ, GRAFSTEIN NEIL, HOROWITZ MARK, GLASSBERG KENNETHI</b></span>. <span style="font-variant: normal">Primary Bladder Neck Dysfunction In Children And Adolescents I: Pelvic Floor Electromyography Lag Time–a New Noninvasive Method To Screen For And Monitor Therapeutic Response</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2005; <b>173</b> (1)</span>: <span style="text-decoration: none">207–211</span>. <span style="text-decoration: underline">DOI: 10.1097/01.ju.0000147269.93699.5a</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/15592077/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/01.ju.0000147269.93699.5a" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="tuite2018a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Tuite GF, Thompson DNP, Austin PF, Bauer SB</b></span>. <span style="font-variant: normal">Evaluation and management of tethered cord syndrome in occult spinal dysraphism: Recommendations from the international children’s continence society</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Neurourol Urodyn</i></span> <span style="text-decoration: none">2018; <b>37</b> (3)</span>: <span style="text-decoration: none">890–903</span>. <span style="text-decoration: underline">DOI: 10.1002/nau.23382</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/28792087/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1002/nau.23382" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="bael2008a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Coplen DE</b></span>. <span style="font-variant: normal">The Relevance of Urodynamic Studies for Urge Syndrome and Dysfunctional Voiding: A Multicenter Controlled Trial in Children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Yearbook of Urology</i></span> <span style="text-decoration: none">2008; <b>2009</b></span>: <span style="text-decoration: none">83–84</span>. <span style="text-decoration: underline">DOI: 10.1016/s0084-4071(09)79276-0</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/18710726/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/s0084-4071(09)79276-0" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="chang2017a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Birder LA</b></span>. <span style="font-variant: normal">Faculty Opinions recommendation of Treatment of daytime urinary incontinence: A standardization document from the International Children’s Continence Society.</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature</i></span> <span style="text-decoration: none">2017; <b>36</b></span>: <span style="text-decoration: none">43–50,</span> <span style="text-decoration: underline">DOI: 10.3410/f.725854188.793540473</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/26473630/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3410/f.725854188.793540473" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="yang2018a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Yang S, Chua ME, Bauer S, Wright A, Brandström P, Hoebeke P, <i>et al.</i></b></span>. <span style="font-variant: normal">Diagnosis and management of bladder bowel dysfunction in children with urinary tract infections: a position statement from the International Children’s Continence Society</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatr Nephrol</i></span> <span style="text-decoration: none">2018; <b>33</b> (12)</span>: <span style="text-decoration: none">2207–2219</span>. <span style="text-decoration: underline">DOI: 10.1007/s00467-017-3799-9</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/28975420/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1007/s00467-017-3799-9" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="gontard2019a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Gontard A von, Kuwertz-Bröking E</b></span>. <span style="font-variant: normal">The Diagnosis and Treatment of Enuresis and Functional Daytime Urinary Incontinence</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Dtsch Arztebl Int</i></span> <span style="text-decoration: none">2019; <b>116</b></span>: <span style="text-decoration: none">279–285,</span> <span style="text-decoration: underline">DOI: 10.3238/arztebl.2019.0279</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/31159915/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3238/arztebl.2019.0279" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="macneily2016a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>MacNeily AE</b></span>. <span style="font-variant: normal">Should Psychological Assessment be a Part of Incontinence Management in Children and Adolescents?</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2016; <b>195</b> (5)</span>: <span style="text-decoration: none">1327–1328</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2016.02.071</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/26891822/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2016.02.071" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="nieuwhof-leppink2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Nieuwhof-Leppink AJ, Hussong J, Chase J, Larsson J, Renson C, Hoebeke P, <i>et al.</i></b></span>. <span style="font-variant: normal">Definitions, indications and practice of urotherapy in children and adolescents: - A standardization document of the International Children’s Continence Society (ICCS)</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2021; <b>17</b> (2)</span>: <span style="text-decoration: none">172–181</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2020.11.006</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/33478902/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2020.11.006" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="borch2013a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Borch L, Hagstroem S, Bower WF, Siggaard Rittig C, Rittig S</b></span>. <span style="font-variant: normal">Bladder and bowel dysfunction and the resolution of urinary incontinence with successful management of bowel symptoms in children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Acta Paediatr</i></span> <span style="text-decoration: none">2013; <b>102</b> (5)</span>: <span style="text-decoration: none">e215–e220</span>. <span style="text-decoration: underline">DOI: 10.1111/apa.12158</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/23368903/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1111/apa.12158" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="hagstroem2009a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Hagstroem S, Mahler B, Madsen B, Djurhuus JC, Rittig S</b></span>. <span style="font-variant: normal">Transcutaneous Electrical Nerve Stimulation for Refractory Daytime Urinary Urge Incontinence</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2009; <b>182</b> (4s)</span>: <span style="text-decoration: none">2072–2078</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2009.05.101</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/19695629/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2009.05.101" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="niemczyk2015a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Niemczyk J, Equit M, Hoffmann L, Gontard A von</b></span>. <span style="font-variant: normal">Incontinence in children with treated attention-deficit/hyperactivity disorder</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2015; <b>11</b> (3)</span>: <span style="text-decoration: none">141.e1–141.e6</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2015.02.009</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/25863677/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2015.02.009" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="schafer2018a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Schäfer SK, Niemczyk J, Gontard A von, Pospeschill M, Becker N, Equit M</b></span>. <span style="font-variant: normal">Standard urotherapy as first-line intervention for daytime incontinence: a meta-analysis</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Eur Child Adolesc Psychiatry</i></span> <span style="text-decoration: none">2018; <b>27</b> (8)</span>: <span style="text-decoration: none">949–964</span>. <span style="text-decoration: underline">DOI: 10.1007/s00787-017-1051-6</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/28948380/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1007/s00787-017-1051-6" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="medina-centeno2020a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Medina-Centeno R</b></span>. <span style="font-variant: normal">Medications for constipation in 2020</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Curr Opin Pediatr</i></span> <span style="text-decoration: none">2020; <b>32</b> (5)</span>: <span style="text-decoration: none">668–673</span>. <span style="text-decoration: underline">DOI: 10.1097/mop.0000000000000938</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/32833797/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/mop.0000000000000938" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="wald2016a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Wald A</b></span>. <span style="font-variant: normal">Constipation</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Jama</i></span> <span style="text-decoration: none">2016; <b>315</b> (2)</span>: <span style="text-decoration: none">185</span>. <span style="text-decoration: underline">DOI: 10.1001/jama.2015.16994</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/26757467/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1001/jama.2015.16994" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="bush2013a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Cruz F</b></span>. <span style="font-variant: normal">Faculty of 1000 evaluation for Randomized, double-blind, placebo-controlled trial of polyethylene glycol (MiraLAX(&amp;#0174)) for urinary urge symptoms.</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>F1000 - Post-Publication Peer Review of the Biomedical Literature</i></span> <span style="text-decoration: none">2013; <b>9</b></span>: <span style="text-decoration: none">597–604,</span> <span style="text-decoration: underline">DOI: 10.3410/f.717964565.793474432</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/23127806/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3410/f.717964565.793474432" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="loening-baucke1997a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Loening-Baucke V</b></span>. <span style="font-variant: normal">Urinary Incontinence and Urinary Tract Infection and Their Resolution With Treatment of Chronic Constipation of Childhood</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatrics</i></span> <span style="text-decoration: none">1997; <b>100</b> (2)</span>: <span style="text-decoration: none">228–232</span>. <span style="text-decoration: underline">DOI: 10.1542/peds.100.2.228</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/9240804/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1542/peds.100.2.228" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="finney2006a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Finney SM, Andersson KE, Gillespie JI, Stewart LH</b></span>. <span style="font-variant: normal">Faculty Opinions recommendation of Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature</i></span> <span style="text-decoration: none">2006; <b>98</b></span>: <span style="text-decoration: none">503–507,</span> <span style="text-decoration: underline">DOI: 10.3410/f.1040721.489750</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/16925744/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3410/f.1040721.489750" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="andersson2011a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Andersson K-E</b></span>. <span style="font-variant: normal">Antimuscarinic Mechanisms and the Overactive Detrusor: An Update</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Eur Urol</i></span> <span style="text-decoration: none">2011; <b>59</b> (3)</span>: <span style="text-decoration: none">377–386</span>. <span style="text-decoration: underline">DOI: 10.1016/j.eururo.2010.11.040</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/21168951/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.eururo.2010.11.040" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="wein2006a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Wein AJ, Rackley RR</b></span>. <span style="font-variant: normal">Overactive Bladder: A Better Understanding of Pathophysiology, Diagnosis and Management</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2006; <b>175</b> (3s)</span>: <span style="text-decoration: none">5–10,</span> <span style="text-decoration: underline">DOI: 10.1016/s0022-5347(05)00313-7</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/16458739/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/s0022-5347(05)00313-7" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="kullmann2008a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Kullmann FA, Artim DE, Birder LA, Groat WC de</b></span>. <span style="font-variant: normal">Activation of Muscarinic Receptors in Rat Bladder Sensory Pathways Alters Reflex Bladder Activity</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Neurosci</i></span> <span style="text-decoration: none">2008; <b>28</b> (8)</span>: <span style="text-decoration: none">1977–1987</span>. <span style="text-decoration: underline">DOI: 10.1523/jneurosci.4694-07.2008</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/18287514/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1523/jneurosci.4694-07.2008" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="andersson2004a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Andersson K</b></span>. <span style="font-variant: normal">Step-by-Step Guide to Treatment of Overactive Bladder (OAB)/Detrusor Overactivity</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Urogynecology: Evidence-Based Clinical Practice</i></span> <span style="text-decoration: none">2004; <b>2</b></span>: <span style="text-decoration: none">77–91</span>. <span style="text-decoration: underline">DOI: 10.1007/1-84628-165-2_7</span></span>.</span></span>   <a href="https://doi.org/10.1007/1-84628-165-2_7" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="ferrara2001a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Ferrara P, D’Aleo CM, Tarquini E, Salvatore S, Salvaggio E</b></span>. <span style="font-variant: normal">Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>BJU Int</i></span> <span style="text-decoration: none">2001; <b>87</b> (7)</span>: <span style="text-decoration: none">674–678</span>. <span style="text-decoration: underline">DOI: 10.1046/j.1464-410x.2001.02152.x</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/11350411/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1046/j.1464-410x.2001.02152.x" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="sommer-a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>SOMMER BARBARAR, O’HARA RUTH, ASKARI NUSHA, KRAEMER HELENAC, KENNEDY WILLIAMA</b></span>. <span style="font-variant: normal">The Effect Of Oxybutynin Treatment On Cognition In Children With Diurnal Incontinence</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2AD; <b>173</b> (6)</span>: <span style="text-decoration: none">2125–2127</span>. <span style="text-decoration: underline">DOI: 10.1097/01.ju.0000157685.83573.79</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/15879864/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/01.ju.0000157685.83573.79" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="giramonti2008a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Giramonti KM, Kogan BA, Halpern LF</b></span>. <span style="font-variant: normal">The effects of anticholinergic drugs on attention span and short-term memory skills in children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Neurourol Urodyn</i></span> <span style="text-decoration: none">2008; <b>27</b> (4)</span>: <span style="text-decoration: none">315–318</span>. <span style="text-decoration: underline">DOI: 10.1002/nau.20507</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/17828786/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1002/nau.20507" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="todorova2001a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Todorova A, Vonderheid-Guth B, Dimpfel W</b></span>. <span style="font-variant: normal">Effects of Tolterodine, Trospium Chloride, and Oxybutynin on the Central Nervous System</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Clin Pharmacol</i></span> <span style="text-decoration: none">2001; <b>41</b> (6)</span>: <span style="text-decoration: none">636–644</span>. <span style="text-decoration: underline">DOI: 10.1177/00912700122010528</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/11402632/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1177/00912700122010528" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="gupta1999a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>GUPTA S, SATHYAN G, LINDEMULDER E, HO P, SHEINER L, AARONS L</b></span>. <span style="font-variant: normal">Quantitative characterization of therapeutic index: Application of mixed-effects modeling to evaluate oxybutynin dose–efficacy and dose–side effect relationships</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Clin Pharmacol Ther</i></span> <span style="text-decoration: none">1999; <b>65</b> (6)</span>: <span style="text-decoration: none">672–684</span>. <span style="text-decoration: underline">DOI: 10.1016/s0009-9236(99)90089-9</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/10391673/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/s0009-9236(99)90089-9" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="austin1999a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>AUSTIN PAULF, HOMSY YVESL, MASEL JONATHANL, CAIN MARKP, CASALE ANTHONYJ, RINK RICHARDC</b></span>. <span style="font-variant: normal">alpha-ADRENERGIC BLOCKADE IN CHILDREN WITH NEUROPATHIC AND NONNEUROPATHIC VOIDING DYSFUNCTION</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">1999; <b>162</b></span>: <span style="text-decoration: none">1064–1067</span>. <span style="text-decoration: underline">DOI: 10.1097/00005392-199909000-00029</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/10458432/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/00005392-199909000-00029" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="franco-a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Franco I, S. C, Collett T, Reda E</b></span>. Unknown. <span style="text-decoration: underline"><span style="text-decoration: none"><i>American Academy of Pediatrics Meeting</i></span>. <span style="text-decoration: none">San Francisco, CA: 2007</span></span>.</span></span> </li>
<li>
<span id="dellis2014a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Dellis AE, Keeley FX, Manolas V, Skolarikos AA</b></span>. <span style="font-variant: normal">Role of \ensuremathα-blockers in the Treatment of Stent-related Symptoms: A Prospective Randomized Control Study</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Urology</i></span> <span style="text-decoration: none">2014; <b>83</b> (1)</span>: <span style="text-decoration: none">56–62</span>. <span style="text-decoration: underline">DOI: 10.1016/j.urology.2013.08.067</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/24210570/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.urology.2013.08.067" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="lepor1997a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Lepor H, Kaplan SA, Klimberg I, Mobley DF, Fawzy A, Gaffney M, <i>et al.</i></b></span>. <span style="font-variant: normal">Doxazosin for Benign Prostatic Hyperplasia: Long-term Efficacy and Safety in Hypertensive and Normotensive Patients</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">1997; <b>157</b> (2)</span>: <span style="text-decoration: none">525–530</span>. <span style="text-decoration: underline">DOI: 10.1016/s0022-5347(01)65193-0</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/8996348/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/s0022-5347(01)65193-0" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="chakraborty2019a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Chakraborty S, Feuerhak K, Muthyala A, Harmsen WS, Bailey KR, Bharucha AE</b></span>. <span style="font-variant: normal">Effects of Alfuzosin, an \ensuremathα1-Adrenergic Antagonist, on Anal Pressures and Bowel Habits in Women With and Without Defecatory Disorders</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Clin Gastroenterol Hepatol</i></span> <span style="text-decoration: none">2019; <b>17</b> (6)</span>: <span style="text-decoration: none">1138–1147.e3</span>. <span style="text-decoration: underline">DOI: 10.1016/j.cgh.2018.08.036</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/30130627/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.cgh.2018.08.036" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="vanderbrink2009a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>VanderBrink BA, Gitlin J, Toro S, Palmer LS</b></span>. <span style="font-variant: normal">Effect of Tamsulosin on Systemic Blood Pressure and Nonneurogenic Dysfunctional Voiding in Children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2009; <b>181</b> (2)</span>: <span style="text-decoration: none">817–822</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2008.10.045</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/19110267/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2008.10.045" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="andersson2009a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Andersson K</b></span>. <span style="font-variant: normal">Ch. 8</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Incontinence</i></span> <span style="text-decoration: none">2009</span></span>.</span></span> </li>
<li>
<span id="uchida2005a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Uchida H, Shishido K, Nomiya M, Yamaguchi O</b></span>. <span style="font-variant: normal">Involvement of cyclic AMP-dependent and -independent mechanisms in the relaxation of rat detrusor muscle via \ensuremathβ-adrenoceptors</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Eur J Pharmacol</i></span> <span style="text-decoration: none">2005; <b>518</b> (2-3)</span>: <span style="text-decoration: none">195–202</span>. <span style="text-decoration: underline">DOI: 10.1016/j.ejphar.2005.06.029</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/16054622/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.ejphar.2005.06.029" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="frazier2005a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Frazier EP, Mathy M-J, Peters SLM, Michel MC</b></span>. <span style="font-variant: normal">Does Cyclic AMP Mediate Rat Urinary Bladder Relaxation by Isoproterenol?</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pharmacol Exp Ther</i></span> <span style="text-decoration: none">2005; <b>313</b> (1)</span>: <span style="text-decoration: none">260–267</span>. <span style="text-decoration: underline">DOI: 10.1124/jpet.104.077768</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/15576470/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1124/jpet.104.077768" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="kobayashi2000a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Kobayashi H, Adachi-Akahane S, Nagao T</b></span>. <span style="font-variant: normal">Involvement of BKCa channels in the relaxation of detrusor muscle via \ensuremathβ-adrenoceptors</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Eur J Pharmacol</i></span> <span style="text-decoration: none">2000; <b>404</b> (1-2)</span>: <span style="text-decoration: none">231–238</span>. <span style="text-decoration: underline">DOI: 10.1016/s0014-2999(00)00606-3</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/10980283/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/s0014-2999(00)00606-3" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="hunsballe2001a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Hunsballe JM, Djurhuus JC</b></span>. <span style="font-variant: normal">Clinical options for imipramine in the management of urinary incontinence</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Urol Res</i></span> <span style="text-decoration: none">2001; <b>29</b> (2)</span>: <span style="text-decoration: none">118–125</span>. <span style="text-decoration: underline">DOI: 10.1007/s002400100175</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/11396729/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1007/s002400100175" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="franco2018b"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Franco I, Arlen AM, Collett-Gardere T, Zelkovic PF</b></span>. <span style="font-variant: normal">Imipramine for refractory daytime incontinence in the pediatric population</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2018; <b>14</b> (1)</span>: <span style="text-decoration: none">58.e1–58.e5</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2017.08.016</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/29100969/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2017.08.016" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="groat2015a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Groat WC de, Griffiths D, Yoshimura N</b></span>. <span style="font-variant: normal">Neural Control of the Lower Urinary Tract</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Compr Physiol</i></span> <span style="text-decoration: none">2015; <b>5</b></span>: <span style="text-decoration: none">327–396</span>. <span style="text-decoration: underline">DOI: 10.1002/cphy.c130056</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/25589273/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1002/cphy.c130056" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="numata2008a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Numata A, Iwata T, Iuchi H, Taniguchi N, Kita M, Wada N, <i>et al.</i></b></span>. <span style="font-variant: normal">Micturition-suppressing region in the periaqueductal gray of the mesencephalon of the cat</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Am J Physiol Regul Integr Comp Physiol</i></span> <span style="text-decoration: none">2008; <b>294</b> (6)</span>: <span style="text-decoration: none">R1996–r2000</span>. <span style="text-decoration: underline">DOI: 10.1152/ajpregu.00393.2006</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/18385467/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1152/ajpregu.00393.2006" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="schuessler2006a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Schuessler B</b></span>. <span style="font-variant: normal">What do we know about duloxetine’s mode of action? Evidence from animals to humans</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Bjog</i></span> <span style="text-decoration: none">2006; <b>113</b></span>: <span style="text-decoration: none">5–9</span>. <span style="text-decoration: underline">DOI: 10.1111/j.1471-0528.2006.00877.x</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/16529563/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1111/j.1471-0528.2006.00877.x" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="roth2008a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Roth TJ, Vandersteen DR, Hollatz P, Inman BA, Reinberg YE</b></span>. <span style="font-variant: normal">Sacral Neuromodulation for the Dysfunctional Elimination Syndrome: A 10-Year Single-center Experience With 105 Consecutive Children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Urology</i></span> <span style="text-decoration: none">2008; <b>84</b> (4)</span>: <span style="text-decoration: none">911–918</span>. <span style="text-decoration: underline">DOI: 10.1016/j.urology.2014.03.059</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/18499169/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.urology.2014.03.059" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="boswell2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Boswell TC, Hollatz P, Hutcheson JC, Vandersteen DR, Reinberg YE</b></span>. <span style="font-variant: normal">Device outcomes in pediatric sacral neuromodulation: A single center series of 187 patients</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2021; <b>17</b> (1)</span>: <span style="text-decoration: none">72.e1–72.e7</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2020.10.010</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/33129672/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2020.10.010" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="bower2001a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>BOWER WF, MOORE KH, ADAMS RD</b></span>. <span style="font-variant: normal">A Pilot Study Of The Home Application Of Transcutaneous Neuromodulation In Children With Urgency Or Urge Incontinence</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2001; <b>166</b></span>: <span style="text-decoration: none">2420–2422</span>. <span style="text-decoration: underline">DOI: 10.1097/00005392-200112000-00112</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/11696802/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/00005392-200112000-00112" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="lordelo2010a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Lordelo P, Teles A, Veiga ML, Correia LC, Barroso U Jr</b></span>. <span style="font-variant: normal">Faculty Opinions recommendation of Transcutaneous electrical nerve stimulation in children with overactive bladder: a randomized clinical trial.</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature</i></span> <span style="text-decoration: none">2010; <b>184</b></span>: <span style="text-decoration: none">683–689,</span> <span style="text-decoration: underline">DOI: 10.3410/f.4324972.4410069</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/20561643/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3410/f.4324972.4410069" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="hoebeke2002a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>HOEBEKE P, RENSON C, PETILLON L, WALLE JVANDE, DE PAEPE H</b></span>. <span style="font-variant: normal">Percutaneous Electrical Nerve Stimulation in Children With Therapy Resistant Nonneuropathic Bladder Sphincter Dysfunction: A Pilot Study</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2002; <b>168</b></span>: <span style="text-decoration: none">2605–2608</span>. <span style="text-decoration: underline">DOI: 10.1097/00005392-200212000-00085</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/12441995/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/00005392-200212000-00085" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="chase2005a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>CHASE JANET, ROBERTSON VALJ, SOUTHWELL BRIDGET, HUTSON JOHN, GIBB SUSIE</b></span>. <span style="font-variant: normal">Pilot study using transcutaneous electrical stimulation (interferential current) to treat chronic treatment-resistant constipation and soiling in children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Gastroenterol Hepatol</i></span> <span style="text-decoration: none">2005; <b>20</b> (7)</span>: <span style="text-decoration: none">1054–1061</span>. <span style="text-decoration: underline">DOI: 10.1111/j.1440-1746.2005.03863.x</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/15955214/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1111/j.1440-1746.2005.03863.x" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="balken2004a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>BALKEN MICHAELR van, VERGUNST HENK, BEMELMANS BARTLH</b></span>. <span style="font-variant: normal">The Use Of Electrical Devices For The Treatment Of Bladder Dysfunction: A Review Of Methods</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2004; <b>172</b> (3)</span>: <span style="text-decoration: none">846–851</span>. <span style="text-decoration: underline">DOI: 10.1097/01.ju.0000134418.21959.98</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/15310981/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/01.ju.0000134418.21959.98" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="capitanucci2009a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Capitanucci ML, Camanni D, Demelas F, Mosiello G, Zaccara A, De Gennaro M</b></span>. <span style="font-variant: normal">Long-Term Efficacy of Percutaneous Tibial Nerve Stimulation for Different Types of Lower Urinary Tract Dysfunction in Children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2009; <b>182</b> (4s)</span>: <span style="text-decoration: none">2056–2061</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2009.03.007</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/19695611/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2009.03.007" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="barroso2013a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Barroso U, Viterbo W, Bittencourt J, Farias T, Lordêlo Patrı́cia</b></span>. <span style="font-variant: normal">Posterior Tibial Nerve Stimulation vs Parasacral Transcutaneous Neuromodulation for Overactive Bladder in Children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2013; <b>190</b> (2)</span>: <span style="text-decoration: none">673–677</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2013.02.034</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/23422257/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2013.02.034" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="jafarov2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Jafarov R, Ceyhan E, Kahraman O, Ceylan T, Dikmen ZG, Tekgul S, <i>et al.</i></b></span>. <span style="font-variant: normal">Efficacy of transcutaneous posterior tibial nerve stimulation in children with functional voiding disorders</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Neurourol Urodyn</i></span> <span style="text-decoration: none">2021; <b>40</b> (1)</span>: <span style="text-decoration: none">404–411</span>. <span style="text-decoration: underline">DOI: 10.1002/nau.24575</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/33205852/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1002/nau.24575" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="austin2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Austin PF, Franco I, Dobremez E, Kroll P, Titanji W, Geib T, <i>et al.</i></b></span>. <span style="font-variant: normal">OnabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Neurourol Urodyn</i></span> <span style="text-decoration: none">2021; <b>40</b> (1)</span>: <span style="text-decoration: none">493–501</span>. <span style="text-decoration: underline">DOI: 10.1002/nau.24588</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/33305474/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1002/nau.24588" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="hoebeke2006a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Hoebeke P, De Caestecker K, Vande Walle J, Dehoorne J, Raes A, Verleyen P, <i>et al.</i></b></span>. <span style="font-variant: normal">The Effect of Botulinum-A Toxin in Incontinent Children With Therapy Resistant Overactive Detrusor</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2006; <b>176</b> (1)</span>: <span style="text-decoration: none">328–331</span>. <span style="text-decoration: underline">DOI: 10.1016/s0022-5347(06)00301-6</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/16753434/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/s0022-5347(06)00301-6" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="lahdes-vasama2011a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Lahdes-Vasama TT, Anttila A, Wahl E, Taskinen S</b></span>. <span style="font-variant: normal">Urodynamic assessment of children treated with botulinum toxin A injections for urge incontinence: a pilot study</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Scand J Urol Nephrol</i></span> <span style="text-decoration: none">2011; <b>45</b> (6)</span>: <span style="text-decoration: none">397–400</span>. <span style="text-decoration: underline">DOI: 10.3109/00365599.2011.590997</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/21740110/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3109/00365599.2011.590997" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="marte2010a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Marte A, Borrelli M, Sabatino MD, Balzo BD, Prezioso M, Pintozzi L, <i>et al.</i></b></span>. <span style="font-variant: normal">Effectiveness of Botulinum-A Toxin for the Treatment of Refractory Overactive Bladder in Children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Eur J Pediatr Surg</i></span> <span style="text-decoration: none">2010; <b>20</b> (03)</span>: <span style="text-decoration: none">153–157</span>. <span style="text-decoration: underline">DOI: 10.1055/s-0029-1246193</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/20112186/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1055/s-0029-1246193" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="chase2010a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Chase J, Austin P, Hoebeke P, McKenna P, International Children’s Continence S</b></span>. <span style="font-variant: normal">The Management of Dysfunctional Voiding in Children: A Report From the Standardisation Committee of the International Children’s Continence Society</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2010; <b>183</b> (4)</span>: <span style="text-decoration: none">1296–1302</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2009.12.059</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/20171678/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2009.12.059" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="clothier2018a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Clothier JC, Wright AJ</b></span>. <span style="font-variant: normal">Dysfunctional voiding: the importance of non-invasive urodynamics in diagnosis and treatment</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatr Nephrol</i></span> <span style="text-decoration: none">2018; <b>33</b> (3)</span>: <span style="text-decoration: none">381–394</span>. <span style="text-decoration: underline">DOI: 10.1007/s00467-017-3679-3</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/28567611/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1007/s00467-017-3679-3" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="palmer2002a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>PALMER LANES, FRANCO ISRAEL, ROTARIO PAUL, REDA EDWARDF, FRIEDMAN STEVENC, KOLLIGIAN MARKE, <i>et al.</i></b></span>. <span style="font-variant: normal">Biofeedback Therapy Expedites the Resolution of Reflux In Older Children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2002; <b>168</b></span>: <span style="text-decoration: none">1699–1703</span>. <span style="text-decoration: underline">DOI: 10.1097/00005392-200210020-00010</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/12352338/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/00005392-200210020-00010" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="resnick2013a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Resnick NM, Perera S, Tadic S, Organist L, Riley MA, Schaefer W, <i>et al.</i></b></span>. <span style="font-variant: normal">What <i>Predicts</i> and what <i>Mediates</i> the response of urge urinary incontinence to biofeedback?</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>Neurourol Urodyn</i></span> <span style="text-decoration: none">2013; <b>32</b> (5)</span>: <span style="text-decoration: none">408–415</span>. <span style="text-decoration: underline">DOI: 10.1002/nau.22347</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/23168606/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1002/nau.22347" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="kibar2007a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Kibar Y, Demir E, Irkilata C, Ors O, Gok F, Dayanc M</b></span>. <span style="font-variant: normal">Effect of Biofeedback Treatment on Spinning Top Urethra in Children with Voiding Dysfunction</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Urology</i></span> <span style="text-decoration: none">2007; <b>70</b> (4)</span>: <span style="text-decoration: none">781–784</span>. <span style="text-decoration: underline">DOI: 10.1016/j.urology.2007.04.054</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/17991555/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.urology.2007.04.054" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="kibar2007b"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Kibar Y, Ors O, Demir E, Kalman S, Sakallioglu O, Dayanc M</b></span>. <span style="font-variant: normal">Results of Biofeedback Treatment on Reflux Resolution Rates in Children with Dysfunctional Voiding and Vesicoureteral Reflux</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Urology</i></span> <span style="text-decoration: none">2007; <b>70</b> (3)</span>: <span style="text-decoration: none">563–566</span>. <span style="text-decoration: underline">DOI: 10.1016/j.urology.2007.03.085</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/17905115/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.urology.2007.03.085" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="bauer2018a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Bauer SB, Vasquez E, Cendron M, Wakamatsu MM, Chow JS</b></span>. <span style="font-variant: normal">Pelvic floor laxity: A not so rare but unrecognized form of daytime urinary incontinence in peripubertal and adolescent girls</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2018; <b>14</b> (6)</span>: <span style="text-decoration: none">544.e1–544.e7</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2018.04.030</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/29909988/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2018.04.030" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="dobrowolska-glazar2017a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Dobrowolska-Glazar BA, Groen LA, Nieuwhof-Leppink AJ, Klijn AJ, Jong TPVM de, Chrzan R</b></span>. <span style="font-variant: normal">Open and Laparoscopic Colposuspension in Girls with Refractory Urinary Incontinence</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Front Pediatr</i></span> <span style="text-decoration: none">2017; <b>5</b></span>: <span style="text-decoration: none">284,</span> <span style="text-decoration: underline">DOI: 10.3389/fped.2017.00284</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/29312913/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3389/fped.2017.00284" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="kort2005a"><span style="font-weight: normal; text-decoration: none"><span style="font-variant: normal">Colposuspension in girls: clinical and urodynamic aspects</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2005; <b>1</b> (2)</span>: <span style="text-decoration: none">69–74</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2004.11.011</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/18947539/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2004.11.011" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Enlace a DOI"><i class="ai2 ai-doi"></i></a>
</li>
</ol>


            
            <!--Last repository commit: 2f61815-->
            <p class="last-modified"><i class="fas fa-clock pr-2"></i><em>Última actualización: 2023-01-29 15:12</em></p>
          </div> <!-- /col -->
        </div> <!-- /row -->
      </div> <!-- /container -->
    </div> <!-- /main -->
    
    <footer id="footer">
      <div class="container">
        <div class="row py-5">
          <div class="col-md-4 d-flex justify-content-center justify-content-md-start mb-4 mb-lg-0">
            <a href="https://beta.pediatricurologybook.com/es/" class="logo pr-0 pr-lg-3 pl-3 pl-md-0">
                <img alt="Pediatric Urology Book" class="img-responsive" src="https://beta.pediatricurologybook.com/assets/site-img/pediatricurologybook-white.svg">
            </a>
          </div>
        </div>
      </div>
      <div class="footer-copyright footer-copyright-style-2">
        <div class="container py-2">
          <div class="row py-4">
            <div class="col-lg-4 d-flex align-items-end justify-content-center justify-content-md-start mb-2 mb-lg-0">
              <p>© 2023 por <a href="https://beta.pediatricurologybook.com/es/">Pediatric Urology Book</a>. Todos los derechos reservados.</p>
            </div>
            <div class="col-lg-8 d-flex flex-column mb-4 mb-lg-0">
              <div class="row">
                <div class="col-12 d-flex align-items-center justify-content-center justify-content-md-end m-0 p-0"><ul class="footer-social-icons social-icons social-icons-clean social-icons-icon-light"><li class="social-icons-github"><a href="https://www.github.com/kylerove/pediatricurologybook" target="_blank" title="GitHub"><i class="fab fa-github-alt"></i></a></li><li class="social-icons-twitter"><a href="https://www.twitter.com/PedUrologyBook" target="_blank" title="Twitter"><i class="fab fa-twitter"></i></a></li><li class="social-icons-mastodon"><a rel="me" href="https://med-mastodon.com/@" target="_blank" title="Mastodon"><i class="fab fa-mastodon"></i></a></li><li class="social-icons-youtube"><a href="https://www.youtube.com/@pediatricurologybook" target="_blank" title="Youtube"><i class="fab fa-youtube"></i></a></li></ul></div>
              </div>
              <div class="row">
                <div class="col-12 d-flex align-items-center justify-content-center justify-content-md-end m-0 p-0">
                  <nav id="sub-menu">
                    <ul>
                      <li><i class="fas fa-map-marker"></i> <a href="https://beta.pediatricurologybook.com/es/site-map/">Mapa del Sitio</a></li><li><i class="fas fa-envelope"></i><a href="mailto:editors%40pediatricurologybook.com" class="opacity-7 pl-1">editors@pediatricurologybook.com</a></li></ul>
                  </nav>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </footer>
</div>
    
    <!-- Search -->
    <script src="https://beta.pediatricurologybook.com/assets/js/search.min.js"></script>
    
    <!-- Vendor -->
    <script src="https://beta.pediatricurologybook.com/assets/vendor/jquery/jquery.min.js"></script>
    <script src="https://beta.pediatricurologybook.com/assets/vendor/jquery.appear/jquery.appear.min.js"></script>
    <script src="https://beta.pediatricurologybook.com/assets/vendor/jquery.easing/jquery.easing.min.js"></script>
    <script src="https://beta.pediatricurologybook.com/assets/vendor/jquery.validation/jquery.validate.min.js"></script>
    <script src="https://beta.pediatricurologybook.com/assets/vendor/jquery.stupidtable/stupidtable.min.js"></script>
    <script src="https://beta.pediatricurologybook.com/assets/vendor/popper/umd/popper.min.js"></script>
    <script src="https://beta.pediatricurologybook.com/assets/vendor/bootstrap/js/bootstrap.min.js"></script>
    
    <!-- Theme Base, Components and Settings -->
    <script src="https://beta.pediatricurologybook.com/assets/js/theme.js"></script>
    
    <!-- Current Page --><script src="https://beta.pediatricurologybook.com/assets/js/pages/chapter.js"></script>
    
    
    <!-- Theme Custom -->
    <script src="https://beta.pediatricurologybook.com/assets/js/custom.js"></script>
    
    <!-- Theme Initialization Files -->
    <script src="https://beta.pediatricurologybook.com/assets/js/theme.init.js"></script>
    
    <!-- Scroll to top -->
    <a class="scroll-to-top hidden-mobile" href="#"><i class="fas fa-chevron-up"></i></a>
    
  </body>
</html>
